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Abstract
Significance: In addition to their classical role in cellular ATP production, mitochondria are of key relevance in
various (patho)physiological mechanisms including second messenger signaling, neuro-transduction, immune
responses and death induction.
Recent Advances: Within cells, mitochondria are motile and display temporal changes in internal and external
structure (‘‘mitochondrial dynamics’’). During the last decade, substantial empirical and in silico evidence was
presented demonstrating that mitochondrial dynamics impacts on mitochondrial function and vice versa.
Critical Issues: However, a comprehensive and quantitative understanding of the bidirectional links between
mitochondrial external shape, internal structure and function (‘‘morphofunction’’) is still lacking. The latter
particularly hampers our understanding of the functional properties and behavior of individual mitochondrial
within single living cells.
Future Directions: In this review we discuss the concept of mitochondrial morphofunction in mammalian cells,
primarily using experimental evidence obtained within the last decade. The topic is introduced by briefly presenting
the central role of mitochondria in cell physiology and the importance of the mitochondrial electron transport chain
(ETC) therein. Next, we summarize in detail how mitochondrial (ultra)structure is controlled and discuss empirical
evidence regarding the equivalence of mitochondrial (ultra)structure and function. Finally, we provide a brief
summary of how mitochondrial morphofunction can be quantified at the level of single cells and mitochondria, how
mitochondrial ultrastructure/volume impacts on mitochondrial bioreactions and intramitochondrial protein diffusion,
and how mitochondrial morphofunction can be targeted by small molecules. Antioxid. Redox Signal. 30, 2066–2109.
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I. Introduction
V irtually every mammalian cell contains mitochon-dria, which are classically recognized as key generators of
cellular energy in the form of adenosine triphosphate (ATP)
(99). In addition, mitochondria constitute an integral part of
the mechanisms that control cell functioning and survival.
This is exemplified by their established physiological role in
cell differentiation (289), immune cell function (40, 252, 261),
cell death regulation (20, 123), calcium homeostasis (77, 109,
110, 434), and neurogenesis (175). In addition, mitochondrial
dysfunction is associated with a multitude of pathophysio-
logical conditions, including metabolic disorders (196),
cancer (6, 53), diabetes (336, 436), and neurodegeneration
(188). Proper mitochondrial function in mammals requires
*1200 genes [MitoCarta 2.0 (43) and MitoMiner 4.0 (369)].
Only a small fraction of these mitochondrial proteins is
encoded by the mitochondrial DNA (mtDNA), of which
multiple copies are present in each individual mitochondrion.
The mtDNA consists of a light (L) and heavy (H) strand, has
a size of 16,569 base pairs, and contains 37 genes (9 on the
L-strand and 28 on the H-strand). These genes encode 13
proteins [all of which are subunits of the mitochondrial oxi-
dative phosphorylation (OXPHOS) system; see section I.A],
22 transfer RNAs, and 2 subunits of the mitochondrial ribo-
some (135). The nuclear DNA (nDNA) encodes the large
majority of mitochondrial proteins, which are synthesized
in the cytosol and imported into the mitochondrion. This
import is carried out by a dedicated machinery of protein
translocases in the mitochondrial outer membrane (TOM)
and inner membrane (TIM), as reviewed in detail elsewere
(172, 422).
A. Mitochondrial adenosine triphosphate production
Mitochondrial adenosine triphosphate (ATP) is primarily
generated by the action of the mitochondrial OXPHOS sys-
tem (Fig. 1). This system is embedded in the mitochondrial
inner membrane (MIM), consists of five multi-subunit
complexes (CI–CV), and is fueled by NADH and FADH2
provided by the glycolysis pathway in the cytosol and the
tricarboxylic acid (TCA) cycle in the mitochondrial matrix
(234, 397). Functionally, the OXPHOS system consists of the
electron transport chain (ETC; comprising CI-CIV) and the
ATP-generating FoF1-ATP synthase (‘‘CV’’). ETC assembly
from its nDNA- and mtDNA-encoded subunits requires as-
sistance of at least 33 nDNA-encoded assembly factors (188).
At a higher structural level, the ETC can be organized in
respiratory supercomplexes (98, 260).
Within the ETC, CI and CII abstract electrons from NADH
and FADH2, respectively, and donate them to Coenzyme Q10
(‘‘Q’’). The latter molecule transports electrons to CIII, from
where they are conveyed to CIV by cytochrome-c (‘‘c’’). At
CIV, the electrons are donated to molecular oxygen to form
water. As an alternative to CI, CII, and CIII, various other
MIM-associated enzymes can donate electrons to Q (241,
284). For instance, by metabolizing: (i) acetyl coenzyme A
(acyl-CoA) (by electron transfer flavoprotein-ubiquinone
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oxidoreductase or ETFQ), (ii) glycerol-3-phosphate (s,n-
Glycerol-3-phosphate dehydrogenase or G3PDH), (iii) proline
(proline dehydrogenase or PRODH), (iv) dihydroorotate
(dihydroorotate dehydrogenase or DHODH), and (v) hydrogen
sulfide (succinate:quinone reductase or SQR). Moreover,
electrons can be donated to cytochrome-c by Mo-pterin and
B-type heme. In this sense, Q and cytochrome-c can be re-
garded as ‘‘junctions,’’ on which different electron-donating
systems converge to feed electrons into the ETC (213). It ap-
pears that the ‘‘alternative’’ electron donors do not simulta-
neously supply electrons to the ETC. Moreover, these enzymes
display tissue and species-specific expression (241). During
electron transport, energy is gradually released and used (at CI,
CIII, and CIV) to expel protons (H+) from the mitochondrial
matrix across the MIM. As a consequence, an inward-directed
trans-MIM proton-motive force (PMF) is generated, consisting
of an electrical (Dw) and chemical (DpH) component (448).
The PMF is utilized by CV to catalyze the formation of ATP
from adenosine diphosphate (ADP) and inorganic phosphate
(Pi) by allowing the controlled re-entry of protons into the
matrix (267, 410). This ATP generation requires Pi import in
the form of PO4
3- by the Pi/H+ symporter (PiC) and the
electrogenic exchange of ADP3- (import) against ATP4- (ex-
port) by the adenine nucleotide translocator (ANT; Fig. 1). This
FIG. 1. Mitochondrial energy metabolism and solute exchange. Schematic visualization of the ATP-generating mito-
chondrial oxidative phosphorylation system (yellow) and TCA cycle. Solute exchangers are indicated in different colors. See
main text for details. This figure was compiled by integrating information from (160, 188, 185, 227, 315, 335).Dw, trans-MIM
electrical gradient; DpH, trans-MIM pH gradient; AA, amino acids; ADP, adenosine diphosphate; ANT, adenine nucleotide
translocator; AQP8, aquaporin-8; ATP, adenosine triphosphate; C, cytochrome-c; CI-CV, complex I–V; FAs, fatty acids; Gln,
glutamine; IMS, intermembrane space; KHE, K+/H+ exchanger; Kv1.3, mitochondrial voltage-activated K+ channel of the
Kv1.3 type; LETM1, leucine zipper-EF-hand-containing transmembrane protein 1; mBKCa, mitochondrial Ca
2+-regulated K+
large conductance channel; MCU, mitochondrial calcium uniporter; mHCX, mitochondrial H+/Ca2+ exchanger; MIM, mi-
tochondrial inner membrane; mKATP, mitochondrial ATP-activated K
+ channel; mNCX, mitochondrial Na+/Ca2+ exchanger;
mNHE, mitochondrial Na+/H+ exchanger; MOM, mitochondrial outer membrane; mPTP, mitochondrial permeability tran-
sition pore; mRYR, mitochondrial ryanodine receptor; mSKCa, mitochondrial small conductance Ca
2+-activated K+ channel;
NNT, nicotinamide nucleotide transhydrogenase; OXPHOS, oxidative phosphorylation; PiC, Pi/H+ symporter; PMF, proton-
motive force; Pyr, pyruvate; Q, Coenzyme Q10; RaM, rapid mode of Ca
2+ uptake; ROS, reactive oxygen species; TCA,
tricarboxylic acid; UCP, uncoupling protein. Color images are available online.
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combined (forward) action of CV and ANT will depolarizeDw,
which is counterbalanced by ETC action. Under pathological
conditions, CV can also hydrolyze ATP and expel protons from
the mitochondrial matrix to sustain Dw (285). This mechanism
requires transport of ATP generated in the cytosol, for instance
by the glycolysis pathway, into the mitochondrial matrix by
ANT reverse mode action.
It is well established that the ETC plays a key role in the
production of mitochondrial reactive oxygen species (ROS),
particularly under pathological conditions. Information about
how ETC-mediated ROS production relates to: (i) other
sources of mitochondrial and cellular ROS, (ii) the spatial
aspects of ROS action, (iii) oxidative stress induction, and
(iv) ROS signaling is discussed in detail elsewhere (21, 89,
190, 241, 365, 425). Regarding the link between the ETC and
redox metabolism, the mitochondrial nicotinamide nucleo-
tide transhydrogenase (NNT) directly couples the trans-MIM
influx of H+ to the transfer of electrons from NADH to NADP
(Fig. 1). This coupling keeps the mitochondrial NADP/
NADPH pool in a reduced state, which protects mitochondria
against oxidative damage (273). The NNT can also operate in
reverse mode, thereby oxidizing the NADP/NADPH pool
and disrupting antioxidant defense (286). Both NAD+/NADH
and NADP+/NADPH play important (regulatory) roles in
mitochondrial/cellular metabolism and redox homeostasis.
These roles, as well as their mechanistic connection and
signaling function in health and disease are discussed in de-
tail elsewhere (140, 145, 161, 435).
B. Cellular ATP production displays
metabolic flexibility
In addition to mitochondrial OXPHOS, the glycolysis
pathway also generates ATP by converting glucose (taken up
by the cell via glucose transporters) into pyruvate. The latter
is either converted into lactate (which can be released into the
extracellular medium) or enters the mitochondrial matrix to
form acyl-CoA as a TCA cycle substrate yielding additional
ATP (Fig. 1). In addition, also fatty acids (FAs) and gluta-
mine (Gln) can serve as TCA substrates (397). Cells display a
substantial degree of metabolic flexibility, meaning that the
balance between glycolysis- and OXPHOS-derived ATP
generation is variable (394). This is exemplified by studies in
C2C12 mouse myoblasts demonstrating that acute OXPHOS
inhibition rapidly increases steady-state glucose uptake/
consumption and that this increase fully compensates for the
reduction in mitochondrial ATP production (219, 220). Al-
ternatively, ATP can be generated by substrate-level phos-
phorylation within the mitochondrial matrix. In this process,
a phosphorylated biomolecule directly transfers a PO3
2-
(phosphoryl) group to ADP or guanosine diphosphate (GDP)
to form ATP or guanosine triphosphate (GTP) (61).
C. ETC function is not only essential
for mitochondrial ATP production
In addition to ATP generation, Dw and/or DpH are crucial
for the activity of transporters that exchange metabolites and
ions between the cytosol, intermembrane space (IMS), and
mitochondrial matrix compartment (Fig. 1) (302, 379). This
exchange is of key importance, for instance to maintain Ca2+
homeostasis and viability in the heart (235). Further, Dw plays
a dual role in the trans-MIM import of mitochondrial pre-
proteins via the TOM/TIM system (422). Given the fact that
Dw is negative on the matrix-facing side of the MIM, it exerts
an electrophoretic effect on the N-terminal mitochondrial
targeting sequence (or ‘‘presequence’’), which often carries a
positive charge (247, 392). In addition, Dw directly activates a
key TIM protein (TIM23), which translocates cleavable pre-
proteins into the IMS or mitochondrial matrix (253).
A less negative (depolarized) Dw has been associated with
reduced mitochondrial ATP production and also connects to
various other (patho) physiological phenomena by: (i) in-
creasing cellular ROS levels (190, 192, 193), (ii) preventing
fusion of the MIM but not of the mitochondrial outer membrane
(MOM; see section III) (243), (iii) increasing the opening
probability of the mitochondrial permeability transition
pore (mPTP), ultimately leading to apoptosis induction (26),
and (iv) stimulating mitochondrial degradation by organelle-
specific autophagy (‘‘mitophagy’’) (137, 382, 393).
D. Mitochondria physically and functionally
interact with other cell constituents
Further emphasizing their central role in cell physiology,
mitochondria physically and functionally interact with various
other cell components, including the cytoskeleton, plasma
membrane (PM), endoplasmic reticulum (ER), Golgi appara-
tus, lipid droplets (LDs), peroxisomes, and lysosomes (316,
395, 428). With respect to peroxisomes, mitochondria are
essential for their de novo biosynthesis from mitochondrial and
ER-derived pre-peroxisomes (376). Mitochondria-ER inter-
actions are currently the best studied and are mediated by
mitochondria-associated membranes. The latter are at the
center of intracellular signaling and other pathways, including
cholesterol and phospholipid synthesis, ROS production, and
mitochondrial calcium uptake/release. In this respect, various
tethering proteins involved in mito-ER coupling have been
identified in yeast and mammalian systems (Fig. 2) (118, 141,
224). Further detailed information about these protein–protein
interactions, as well as their functional relevance, is presented
elsewhere (50, 72, 118, 121, 141, 190, 224).
II. Mitochondrial (Ultra)Structural Dynamics
Mitochondria consist of a double membrane system, in which
the MOM surrounds the MIM (Fig. 3A, B). The latter constitutes
the boundary of the mitochondrial matrix compartment and
contains many folds (cristae) that protrude into this compart-
ment, thereby enlarging the MIM surface area. The MIM and
MOM are separated by the mitochondrial IMS and are partially
connected via contact sites that are involved in cristae organi-
zation (309). Important structural features of the mitochondrial
matrix and cristae system include the inner boundary membrane
(IBM), cristae junction (CJ), and cristae membrane (CM;
Fig. 3C, D). Parameters describing mitochondrial (ultra)struc-
ture include the distance between the MIM and MOM (marked
‘‘a’’), the intracristae space (marked ‘‘b’’), and the distance
between adjacent cristae (‘‘inter-cristae space’’) (403).
Maintaining CM integrity is of key importance for proper
OXPHOS functioning (68, 149). The latter is illustrated
by analyis of the yeast Saccharomyces cerevisiae using
superresolution microscopy (see section IV.D) and cryo-
immunogold electron microscopy (EM). This revealed that
mtDNA-encoded subunits of CIII and CIV are inserted at
different sites of the MIM when compared with CV subunits
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(374). In addition, it was found that early (but not late) steps
in CIII and CIV assembly occur at the IBM, whereas CV
assembly is carried out in the CM. This suggests that al-
terations in cristae structure directly but differentially affect
the assembly of OXPHOS complexes. Net mitochondrial
external/internal morphology and positioning greatly dif-
fers between cell types (39, 69, 201, 389) and dynamically
changes over time (Fig. 4; ‘‘mitochondrial dynamics’’).
These changes require mitochondrial movement via me-
chanical interactions with the cytoskeleton, the functional
impact and molecular mechanisms of which are discussed
elsewhere (29, 223, 264, 362). In addition, mitochondrial
external and internal morphology is affected by: (i) fission/
fusion events (51, 297, 392, 420), (ii) chemiosmosis-related
swelling/shrinking (160), (iii) the composition and physi-
cochemical properties of the MOM and MIM (131), and (iv)
the nature of the extracellular matrix (19).
As the integrated result of the mechanisms described earlier,
mitochondrial external morphology ranges from elongated
tubular structures (Fig. 5A–C) to donut-shaped organelles
(Fig. 5D, arrows) and often displays heterogeneity within the
same cell (Fig. 5C–E). It was proposed that this morphological
plasticity allows: (i) mixing of mitochondrial content, (ii) re-
distribution of damaged proteins and lipids between mito-
chondria in stress reduction, (iii) local functioning of (subsets
of) mitochondria within the cell, and (iv) mitophagy (179).
Importantly, mitochondria cannot be generated de novo (363).
This means that mitochondrial fission is crucial to allow their
inheritance by both daughter cells during cell division.
In vivo mouse studies revealed that mtDNA-devoid tumor
cells acquired mtDNA from host cells, suggesting transfer of
whole mitochondria and/or their content between cells (381). In
agreement with this idea, transcellular exchange of individual
mitochondria via nanotubular structures (‘‘nanotunneling’’) has
been demonstrated under certain conditions (255, 338, 404). On
the other hand, it appears that mtDNA can be transferred be-
tween cells via exchange of extracellular vesicles (343). Also,
the MIM displays heterogeneity and dynamic behavior (Fig. 6)
and, although a rare event, cristae can disappear or form within
a matter of seconds (87). Fission and fusion of the MOM and
MIM are executed by a core machinery of nine currently
identified proteins (Fig. 7A) (51, 308, 337). Directly below, we
discuss these fission and fusion mechanisms in more detail.
A. Fission of the mitochondrial outer membrane
MOM fission is carried out by dynamin-related protein 1
(DRP1; Fig. 8), a cytosolic GTPase (314, 367). This protein
also mediates peroxisome fission (see section II.F). The large
majority of DRP1 protein appears to reside in the cytosol,
from which it is recruited to the MOM by four currently
unknown adaptor proteins (Fig. 8): (i) fission protein 1 (FIS1)
(230, 300, 437), (ii) mitochondrial fission factor (MFF) (230,
299, 300), and (iii) mitochondrial elongation factor 1 (MIEF1/
MID51) and mitochondrial elongation factor 2 (MIEF2/
MID49) (229, 230, 300, 301, 331, 439, 445).
In principle, mitochondrial fission is a stochastic process
(200) during which DRP1 is recruited to the MOM. Once
recruited, DRP1 monomers oligomerize into a contractile ring-
like structure. On GTP hydrolysis, this structure decreases
its diameter, thereby inducing mitochondrial fission (41, 112,
250). Quantitative analysis of DRP1 protein distribution in
FIG. 2. Selected proteins involved in mitochondria-ER
tethering. Tethering protein complexes include the ER-
ERMES, MFNs, and the VDAC-containing complex in-
volved in mitochondrial calcium uptake. BAP31, B cell
receptor associated protein 31; ER, endoplasmic reticulum;
FIS1, fission protein 1; GEM1, GTPase EF-hand protein of
mitochondria 1; GRP75, glucose-regulated protein of 75 kD;
IP3R, inositol 1,4,5-trisphosphate receptor; LAM6, lipid
transfer protein anchored at membrane contact site 6; MFNs,
mitofusins; MMM1, maintenance of mitochondrial morphol-
ogy 1; MDM10, mitochondrial distribution and morphology
10; MDM12, mitochondrial distribution and morphology 12;
MDM34, mitochondrial distribution and morphology 34;
PDZD8, PDZ domain-containing 8; ORP5/8, oxysterol-
binding protein-related proteins 5 and 8; PTPIP51, protein
tyrosine phosphatase-interacting protein 51; RRBP1, ribosome-
binding protein 1; SYNJ2BP, synaptojanin 2 binding protein;
TOM7, translocase of the outer mitochondrial membrane 7;
TOM70, translocase of the outer mitochondrial membrane 70;
TOM71, translocase of the outer mitochondrial membrane 71;
VAPB, VAMP (vesicle-associated membrane protein) associ-
ated protein B and C; VDAC, voltage-dependent anion channel.
Color images are available online.
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HeLa cells expressing GFP-tagged DRP1 suggests that cyto-
solic GFP-DRP1 predominantly exists in a tetrameric form
and constitutes*50% of the total GFP-DRP1 pool (258). The
latter study estimated that a functional DRP1 fission complex
contains *100 DRP1 molecules. A population of DRP1
oligomers was detected on ER membranes, being distinct from
mitochondrial or peroxisome-associated oligomers (162). On
MFF knockdown, DRP1 oligomer levels at the ER, mito-
chondria, and peroxisomes were reduced, suggesting that
DRP1 can use these three organelle membranes as oligomer-
ization platforms.
ER tubules are involved in marking the site of mito-
chondrial division (111) and mtDNA replication (216).
Mitochondrial ER-mediated constriction further involves
inverted formin 2, an ER-associated actin modulator that
induced actin polymerization at the ER-mitochondrial
contact site (197). Additional actin-binding proteins (e.g.
SPIRE1C; 211, 245) and lysosome-mitochondrial contacts
also play a role in marking DRP1- and ER-positive sites of
mitochondrial fission (428). Mechanistically, these contacts
were promoted by active (GTP-bound) RAB7, a lysosomal
GTPase that is a member of the RAS oncogene family. In-
terestingly, disconnection of lysosome-mitochondria con-
tacts involved FIS1-mediated recruitment of TBC1D15
(TBC1 Domain Family Member 15). The latter is a GAP
(GTPase-accelerating protein) of RAB7, which deactivates
RAB7 by promoting its GTP hydrolyzing activity (428). In
yeast, FIS1 was identified as a factor involved in the mito-
chondrial recruitment of DRP1 (DNM1) (202). However, it
appears that FIS1 is not essential for mitochondrial fission in
mammals (296, 299) but binds to MFF on the MOM, which,
subsequently, attaches to a complex containing FIS1 and ER
proteins at the mitochondria-ER interface (360). This study
also provided evidence that FIS1 is not strictly required for
mitochondrial fission but is involved in mitophagy. In this
sense, inactivation of FIS1 gives rise to formation of LGG-
1/LC3 aggregates (360).
Taken together, the current mechanistic insights suggest
that MFF is the main DRP1 adaptor protein that, together with
MIEF1/MID51 and MIEF2/MID49, controls DRP1 ring for-
mation and constriction (169, 200). It was suggested that MIEF1/
MID51 and MIEF2/MID49 also regulate the association of
DRP1 with MFF in a trimeric DRP1-MIEF/MID-MFF complex
(439). In addition, evidence was provided that MFF can act as a
biomechanical membrane-bound force sensor (139). This would
allow recruitment of the fission machinery to mechanically
strained sites of the MOM. Recently, a new member of the
mitochondrial division machinery, dynamin 2 (DYN2; Fig. 8),
was discovered (210). DYN2 is ubiquitously expressed and acts
together with DRP1 in sequential constriction, ultimately leading
to a final DYN2-mediated step in mitochondrial fission (210).
B. Fusion of the MOM
Mitochondrial fusion requires sequential merging of the
MOM and MIM of the two precursor mitochondria (243,
372). MOM fusion is mediated by the GTPases mitofusin 1
and 2 (MFN1/MFN2) (46, 212, 334, 344, 431). This process
is well studied (100, 211) and is mediated by homotypic and
heterotypic interactions between MFN1 and MFN2 on op-
posing mitochondria (56). These interactions are believed to
involve (indirect) formation of disulfide bridges (249, 364).
Both mitofusins (Fig. 8) contain a GTPase (G) domain, a
coiled-coil domain (heptad repeat domain 1 or HR1), an
MOM-spanning transmembrane domain (TM), and a second
IMS-protruding coiled-coil domain (heptad repeat domain 2)
(116). It was recently demonstrated that mitofusins are single
MOM-spanning proteins with their N-terminus facing out-
ward into the cytosol and their C-terminus protruding into the
IMS (249). Analysis of the MFN1 crystal structure suggests
FIG. 3. Mitochondrial ultra-
structure. (A) EM image depicting
a mitochondrion (HeLa cell). The
white box indicates the magnified
view in (C). (B) Schematic repre-
sentation of mitochondrial ultra-
structure showing the mitochondrial
matrix enveloped by the MIM and
MOM. Between the MIM and
MOM lies the IMS. (C) Magnifi-
cation of the box in (A) to illustrate
mitochondrial ultrastructure depict-
ing the IBM, CJ, and CM. (D)
Schematic representation of mito-
chondrial ultrastructure. Structural
parameters include the distance be-
tween the MIM and MOM (marked
‘‘a’’) and the intracristae space
(marked ‘‘b’’). (D) was adapted
from (404). CJ, cristae junction;
CM, cristae membrane; EM, electron
microscopy; IBM, inner boundary
membrane. Color images are avail-
able online.
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that it forms homodimers during mitochondrial fusion by
conformational changes that promote GTPase-domain (G-
domain) dimerization (46, 321). This is in contrast with
previous evidence suggesting that the C-terminal antiparallel
coiled-coil domain of MFN1 plays a key role in tethering
(105, 199). It was further suggested that MFN1 might use a
two-step tethering mechanism consisting of a nucleotide-
regulated dimerization of the G domains and subsequent in-
teraction between the coiled-coil domains (46). Using in situ
and in vitro fusion assays, it was demonstrated that interac-
tion with the surface of the lipid bilayer induces folding of a
conserved amphipathic helix in HR1 (75). This suggests a
mechanism in which HR1 destabilizes the MOM lipid bila-
yer, especially in membrane regions displaying defects in
lipid packing, to facilitate MOM fusion.
C. Mitochondrial inner membrane fusion
MIM fusion requires the action of the GTPase optic atrophy
protein 1 (OPA1) (108, 128, 293, 371). GTP is supplied to
OPA1 by nucleosidediphosphate kinases, which produce GTP
through ATP-driven conversion of GDP (32). The OPA1 pro-
tein exists in eight different isoforms (splice variants, Sp1–Sp8)
due to differential splicing (Fig. 8) (51). Each OPA1 isoform
contains various domains including an N-terminal mitochon-
drial targeting sequence (MTS), a TM, and a protease cleavage
site (S1). Four of the eight OPA1 isoforms also contain an
additional (S2) protease cleavage site (51). After mitochon-
drial import of the OPA1 precursor, its MTS is cleaved off by
the matrix-soluble protein peptidase, yielding an MIM-
anchored ‘‘Long’’ OPA1 form (‘‘L-OPA1’’; Fig. 9). Cleavage
of the OPA1 precursor at S1 or S2 yields ‘‘Short’’ OPA1 forms
(‘‘S-OPA1’’). Proteolytic processing of OPA1 at S1 and S2
constitutes a major regulatory mechanism (371) that is carried
out by a complex proteolysis network (51). Two mitochondrial
proteases, OMA1 (‘‘overlapping activity with m-AAA prote-
ase’’) and YME1L (‘‘Human yme1-like protein’’), are respon-
sible for L-OPA1 cleavage at S1 and S2, respectively (Fig. 9) (8,
51, 265, 323). Because both L-OPA1 and S-OPA1 forms need
to be present in a proper ratio for MIM fusion, it appears that
some OPA1 processing is always required.
D. Regulation and maintenance of cristae structure
1. Role of OPA1. Experimental studies in HeLa cells
revealed that OPA1 knockdown induced mitochondrial
FIG. 4. Live-cell dynamics of mitochon-
drial external structure. Primary mouse
myoblasts from skeletal muscle were stained
with rhodamine 123 and visualized by using
fluorescence microscopy at an interval of
40 s. Individual mitochondria (arrow) were
motile and displayed volume and structural
changes. Color images are available online.
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fragmentation, Dw dissipation, and cristae disorganization,
which were associated with cytochrome-c release and caspase-
dependent apoptotic cell (AC) death (294). These observations
are compatible with the observation that OPA1, independently
of its role in MIM fusion and without interfering with activa-
tion of BAX and BAK, prevents mitochondrial cytochrome-c
release, thereby protecting against apoptosis induction (108).
Mechanistically, this is achieved by oligomerization of MIM-
anchored L-OPA1 and soluble S-OPA1, which maintains
tightness of the CJs during apoptosis (Fig. 10A).
The Presenilin-associated rhomboid-like (PARL) protease
is involved in this OPA1-dependent protection, since Parl-/-
mice displayed reduced levels of S-OPA1 and PARL-/- mi-
tochondria exhibited accelerated cristae remodeling and
cytochrome-c release during apoptosis (65). Knockdown of
OPA1 in HeLa cells specifically reduced CM dynamics,
whereas the IBM remained flexible (124). Recently, an
elegant mechanistic framework was presented that inte-
grates these earlier observations with the existence of
OPA1 isoforms and OMA1/YME1L-mediated OPA1
processing (79–81). In this model, all eight OPA1 isoforms
(Fig. 9) are proposed to be involved in organization of
OXPHOS supercomplexes, cristae shaping, and mtDNA
maintenance. Independent of mitochondrial morphology,
L-OPA1 and S-OPA1 isoforms support mitochondrial fu-
sion and preserve mitochondrial bioenergetics, respec-
tively. In addition to OMA1, YME1L, and PARL, various
other biomolecules interact with or affect OPA1 function
FIG. 5. Mitochondrial morphology visualized by using live-cell fluorescence microscopy. (A) Left panel: visualization
of mitochondrial structure in a primary fibroblast of a patient carrying a compound heterozygous mutation (R59X/T423M)
in the gene encoding the NDUFV1 subunit of CI (left panel). Cells were stained with the mitochondria-accumulating cation
rhodamine 123. Right panel: PHSFs (control CT5120) co-stained with rhodamine 123 and the membrane-staining reporter
molecule FM1-43. (B) Visualization of mitochondrial structure in a PHSF (control CT5120) using DIC imaging (also
known as Nomarski microscopy). Cells were cultured in the presence of the CI inhibitor rotenone (100 nM, 72 h). The white
box shows a zoom-in of the indicated region. (C) Confocal image of a control PHSF stained with JC-1, which accumulates
in the mitochondrial matrix according to the Dw across the MIM. The right part of the image shows a zoom-in of the
indicated region. Arrows mark regions of JC-1 aggregation (top arrow; red), suggesting a more negative Dw, and inho-
mogeneous JC-1 signals across mitochondrial filaments (middle and lower arrow). (D) Microscopy image of a PHSF
(control CT5120) stained with MitoTracker Green FM. This image was obtained by using video-rate microscopy and
deconvolved off-line. Arrows mark ‘‘donut-shaped’’ mitochondria. (E) Collage of microscopy images visualizing a large
mitochondrial network in rhodamine 123-stained PHSFs of a patient carrying a mutation (R228Q) in the gene encoding
the NDUFS2 subunit of CI. These cells were imaged following immortalization and chromosome transfer. Magnifications
(a, a’, b, c, d) show mitochondrial morphologies throughout the cell. The magnified images were contrast-optimized for
visualization purposes (an asterisk shows the cytosol). DIC, differential interference contrast; PHSFs, primary human skin
fibroblasts. Color images are available online.
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to regulate or maintain MIM structure. These include
MFN1, MFN2, BAX/BAK, Paraplegin (SPG7), prohibitin
2 (PHB2), and mtDNA polymerase gamma. Detailed in-
formation on these interactions and their functional impact
is provided in the Supplementary Table and elsewhere (67,
74, 447).
2. Role of mitochondrial contact site and cristae organi-
zation. In addition to OPA1, another key player in mito-
chondrial ultrastructural maintenance is the mitochondrial
contact site and cristae organization (MICOS) system
(Fig. 10B). Currently, this system is best understood in yeast
(327, 398, 427). The MICOS complex impacts metabolite
handling, cellular signaling, mitochondrial membrane ar-
chitecture, and mitochondrial protein import. This coupling
is mediated by MICOS interactions with: (i) the MOM pro-
tein Porin/VDAC (voltage-dependent anion channel; inter-
action with the MICOS subunit MIC60), (ii) the protein
FIG. 6. Mitochondrial heterogeneity and live-cell dynamics of mitochondrial internal structure. (A) Visualization of
mtHSP70 antibody staining localized to mitochondria in PHSFs (control CT5120) by using fluorescence microscopy. (B)
Magnification of a region of interest in (A) (dotted lines). The image was rotated 90 degrees clock-wise for visualization
purposes. Arrows indicate inhomogeneous mitochondrial mtHSP70 staining. (C) First fluorescence microscopy image from
a time-lapse recording of PHSFs (control CT5120) expressing a mitochondria-targeted fluorescent protein (COX8-EYFP).
Arrows indicate inhomogeneous mitochondrial EYFP fluorescence signals. (D) Fluorescence microscopy images depicting a
time-lapse recording from part of a primary fibroblast of a patient carrying a compound heterozygous mutation (R59X/
T423M) in the gene encoding the NDUFV1 subunit of CI. This cell expressed COX8-EYFP and was visualized by using
video-rate confocal microscopy (1 s interval; 30 images/s were averaged). Arrows indicate inhomogeneous mitochondrial
EYFP fluorescence signals. (E) Magnification of a region of interest in (D) (dotted lines). The image was put in a horizontal
position for visualization purposes. Dynamic changes in the mitochondrial EYFP fluorescence signal were observed. Color
images are available online.
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FIG. 7. Key mechanisms that govern dynamic changes in mitochondrial internal/external structure and volume.
(A) Mitochondrial fission and fusion is carried out by a set of nine proteins (MFN1, MFN2, OPA1, DRP1, DYN2, FIS1,
MIEF1, MIEF2, and MFF). A fragmented mitochondrial morphology allows mitochondria to undergo mitophagy whereas
the latter is prevented by mitochondrial elongation and hyperfusion (observed during stress and starvation conditions).
In addition, mitochondrial matrix volume can increase as a function of metabolic demand and/or as a consequence of
stress. Ultimately, the latter will lead to mitochondrial (ultra)structural remodeling and apoptosis induction. During
(patho)physiological conditions (reversible) remodeling of mitochondrial internal and external structure is linked to (re-
versible) changes in mitochondrial function (see section IV for further details). (B) Typical examples of PHSFs (control
CT5120) stained with TMRM and visualized by using fluorescence microscopy (left panels; contrast-optimized). Image
processing was applied to obtain ‘‘binary’’ images depicting white mitochondrial objects on a black background (right
panels, see Fig. 13A). The cells displayed a ‘‘fragmented’’ mitochondrial morphology (upper panels; cells treated with
12.5 lM of the glutathione-neosynthesis inhibitor L-Buthionine-sulfoximine during 24 h) and a ‘‘filamentous’’ mitochon-
drial morphology (lower panels; vehicle-treated cells). (C) Quantitative analysis of the mitochondrial morphology for the
cells (marked with asterisks) in (B). Relative to the filamentous mitochondrial phenotype (green), the fragmented (L-
Buthionine-sulfoximine-induced) phenotype 9 (red) was characterized by an increased number of mitochondria per cell
(Nc) and reduced mitochondrial area (Am; a measure of mitochondrial size/volume; **p = 0.004), aspect ratio (AR; a
measure of mitochondrial length; **p= 0.001), and formfactor (F; a combined measure of mitochondrial length and degree
of branching; **p = 0.003). DRP1, dynamin-related protein 1; DYN2, dynamin 2; MFF, mitochondrial fission factor; MFN1/
MFN2, mitofusin 1 and 2; MIEF1/MID51, mitochondrial elongation factor 1; MIEF2/MID49, mitochondrial elongation
factor 2; OPA1, optic atrophy protein 1; TMRM, tetramethylrhodamine. Color images are available online.
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sorting and assembly machinery (SAM; MIC60 interaction),
(iii) the protein translocase of the MOM (TOM; MIC60
interaction), (iv) the presequence translocase of the MIM
(TIM23), (v) mtDNA, (vi) the ETC, and (vii) CV (352).
Recent evidence suggests that MICOS also interacts with the
MIM ATPase ATAD3A, and that the latter protein assists in
stabilizing mitochondrial cristae, potentially via interactions
with the MOM (307). Subunit MIC10 plays a central role in
the yeast MICOS system (31), and MIC10 oligomerization
induces MOM bending at CJs (17). Electron tomography
analysis revealed that MIC19 and MIC60 were enriched in-
side cristae and localized at CJs (346). Moreover, the latter
study provided evidence that MIC19 interacted with subunit
IV of CIV. Various interactions between MICOS subunits
and mitochondrial fission/fusion proteins have been reported
(Supplementary Table). For instance, the core MICOS pro-
tein MIC60 binds to OPA1 and together they control the
number and stability of CJs (119).
3. Role of CV. Another important determinant of mito-
chondrial ultrastructure is CV of the OXPHOS system, the
dimerization of which induces MIM curvature (Fig. 10B)
(133). Dissociation of CV dimers into monomers was par-
alleled by inversion of MOM curvature at the CV site, MOM
vesiculation, and cristae structural aberrations during aging
in the model organism Podospora anserina (76). Evidence
was provided that CV dimerization is mediated by interac-
tions between its Fo and F1 domains and promotes cristae
formation (262). Alternatively, it was proposed that CV di-
merization is mediated by connecting its two F1 moieties
by a protein bridge formed by ATPase inhibitory factor 1
(IF1) (262). Compatible with this connecting function, IF1
FIG. 8. Core mitochondrial fission and
fusion proteins. Domain structure of the nine
proteins controlling mitochondrial fission
(red) and fusion (green). Each protein is
drawn to scale according to its length in AA.
Further details are provided in the main text.
This figure was compiled by integrating
information from (206, 208, 238, 425, 449).
G-domain, GTPase domain; GED, GTPase
effector domain; MPP, matrix-soluble protein
peptidase; HR1, heptad repeat domain 1; HR2,
heptad repeat domain 2; MTS, mitochondrial
targeting sequence; PH, pleckstrin-homology
domain; PRD, proline-rich domain; S1, pro-
tease cleavage site 1 for OMA1; S2, protease
cleavage site 2 for YME1L; Sp, splice vari-
ant; TM, transmembrane domain. Color
images are available online.
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overexpression and knockdown increased and decreased
mitochondrial volume and mitochondrial cristae density,
respectively (44, 45). IF1 limits mitochondrial ATP con-
sumption when mitochondrial respiration is impaired by in-
hibiting CV reverse-mode action (44). Moreover, IF1 inhibits
OMA1-mediated processing of OPA1, thereby impeding
cristae remodeling during apoptosis (101). Evidence in yeast
suggests that the extent of CV dimerization and/or cluster-
ing depends on the cellular demand for OXPHOS-generated
ATP (164).
4. Role of MitoNEET. Interestingly, adjacent mitoc-
hondria display a coordinated cristae architecture at inter-
mitochondrial junctions (IMJs), where cristae form parallel
arrays that are perpendicular to the IMJ, suggesting a role in
electrochemical coupling (311). This study also provided
evidence that MFNs are not required for IMJ formation
and that IMJs are dynamic structures, the amount and
function of which are dynamically regulated by the bioen-
ergetic state of the mitochondrion. It was recently demon-
strated that knockdown of MitoNEET (CDGSH iron-sulfur
domain-containing protein 1 or CISD1), a dimeric outer mem-
brane protein, reduced IMJ frequency (402). This suggests
that MitoNEET plays a role in the regulation of IMJ
formation.
E. Role of ‘‘non-core’’ proteins in mitochondrial fission,
fusion, and ultrastructure
In addition to the ‘‘well-studied’’ mechanisms described
earlier, there is a large body of empirical evidence in higher
eukaryotes reporting additional proteins and pathways that
affect mitochondrial (ultra)structure. These effects are me-
diated not only by these proteins interacting with core fission/
fusion proteins (Supplementary Table) but also by other
mechanisms. For instance, the mitochondrial protein TMEM11
(transmembrane protein 11) regulated mitochondrial mor-
phology by a mechanism that was independent of DRP1/
MFN (332). TMEM11 is the human orthologue of Droso-
phila PM1 (pantagruelian mitochondrion 1), which controls
cristae biogenesis and mitochondrial diameter in flies (236).
Also, TMEM135 (transmembrane protein 135) localized to
mitochondria and its overexpression and/or mutation dis-
turbed mitochondrial dynamics (206).
Overexpression and knockdown of optic atrophy 3 (OPA3),
an integral MOM protein of which the gene is mutated in
FIG. 9. Proteolytic processing of OPA1
isoforms. As a result of differential splicing,
the OPA1 protein exists in eight different
isoforms (Sp1-Sp8). (A) Four OPA1 splice
variants (Sp1, Sp2, Sp3, and Sp5) contain a
single protease cleavage site (S1). OPA1 is
imported into the mitochondrion as a pre-
protein, after which its targeting sequence
(MTS) is cleaved off by the MPP. This yields
a ‘‘long’’ OPA1 form (L-OPA1), which is
MIM-anchored and processed by OMA1 on
mitochondrial dysfunction. This yields a
‘‘short’’ OPA1 form (S-OPA1), which is not
MIM-anchored. (B) Similar to panel A, but
now for the four other OPA1 splice variants
(Sp4, Sp6, Sp7, and Sp8). In addition to S1,
these contain a second protease cleavage site
(S2), which is processed by YME1L on mi-
tochondrial dysfunction. Further details are
provided in the main text. This figure was
compiled by integrating information from
(151, 238, 294, 371). Color images are
available online.
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hereditary optic neuropathies, induced mitochondrial fragmen-
tation and elongation, respectively (340). OPA3-overexpressing
cells did not display spontaneous AC death but were sensitized
to apoptosis induction by staurosporine- and tumor necrosis
factor-related apoptosis-inducing ligand. This suggests that
OPA1 and OPA3 exert different functions in apoptosis. OPA3
gene mutations were associated with mitochondrial frag-
mentation in patient fibroblasts (125). Mitochondrial frag-
mentation and spontaneous apoptosis were also induced after
overexpression of a pathological OPA3 mutant (G93S),




Binds to the ER and regulates ER morphology. (314, 438)
Stimulates tBID-induced BAX oligomerization and cytochrome-c release by promoting tethering
and hemifusion of membranes in vitro.
(269)
Localizes to the Golgi complex in some cell lines, potentially acting as a component of the apical
sorting machinery at the trans-Golgi network.
(33)
During synaptic stimulation, BCL-XL translocates to clathrin-coated pits in a calmodulin-dependent
manner and forms a complex with DRP1, MFF, and clathrin.
(217)
The DRP1-ABCD isoform is located at lysosomes and enriched at the inter-organelle interface
between mitochondria and lysosomes/late endosomes. This enrichment depends on lysosomal pH.
(153)
FIS1
Peroxisomal adaptor for DRP1 (183)
Interacts with BAP31 at the ER membrane to create a platform for activation
of procaspase-8 during apoptosis.
(154)
MFF
Peroxisomal adaptor for DRP1 (114)
During synaptic stimulation, BCL-XL translocates to clathrin-coated pits in a calmodulin-dependent
manner and forms a complex with DRP1, MFF, and clathrin.
(217)
MFN1
ER-MOM tethering. MFN2 on the ER engages heterotypic complexes with MFN1
on the surface of mitochondria.
(77)
MFN2
ER-MOM tethering. MFN2 on the ER engages in homotypic and heterotypic complexes with MFN1
or MFN2 on the surface of mitochondria. MFN2 knockdown increased Ca2+ transfer from
the ER to mitochondria.
(14, 77, 203)
Suppresses vascular smooth muscle cell proliferation independent of its role in mitochondrial fusion.
This growth suppression is inhibited by PKA-mediated phosphorylation of the Ser442 residue of MFN2.
(446)
Enhances mitochondrial metabolism. (312)
MFN2 but not MFN1 is an ER stress-inducible protein that is required for the proper temporal
sequence of the ER stress response.
(282)
MFN2 physically interacts with and is an upstream modulator of PERK, a protein involved
in the response to ER stress stimuli by triggering the UPR.
(272)
In the heart, MFN2 serves as an adaptor protein to mediate fusion of autophagosomes
and lysosomes.
(444)
Involved in trafficking of STIM1 to the ER-PM junction and subsequent activation
of CRAC channel activity after Dw depolarization.
(366)
Interacts with MIRO and MILTON to allow transport of axonal mitochondria. (263)
MFN2 overexpression induces apoptosis in cardiac myocytes. (361)
MFN2 exerts antiproliferative effects. (55)
In BAT, MFN2 mediates the docking of mitochondria to LDs, allowing an efficient fatty acid
transfer to mitochondria for b-oxidation.
(37)
MFN2 acts as a Parkin receptor on dysfunctional mitochondria. (57)
MFN2 negatively regulates NFAT in the maintenance of HSCs with extensive lymphoid potential.
In these cells, MFN2 increases ER-mitochondria tethering and therefore the cytosolic
Ca2+-buffering capacity to inhibit NFAT activity.
(232)




Organizes a supramolecular complex containing both PKA and Perilipin (PLIN1). OPA1 targeting
of PKA to LDs is necessary for hormonal control of perilipin phosphorylation and lipolysis.
(313)
BAP31, B cell receptor associated protein 31; BAT, brown adipose tissue; CRAC, calcium release-activated calcium channel; DRP1,
dynamin-related protein 1; ER, endoplasmic reticulum; FIS1, fission protein 1; HSC, hematopoietic stem cell; LD, lipid droplet; MFF,
mitochondrial fission factor; MFN1/MFN2, mitofusin 1 and 2; MIRO, mitochondrial RHO GTPase; MOM, mitochondrial outer membrane;
NFAT, nuclear factor of activated T cells; OPA1, optic atrophy protein 1; PERK, protein kinase RNA (PKR)-like ER kinase; PKA, protein
kinase A; PM, plasma membrane; STIM1, stromal interaction molecule 1; UPR, unfolded protein response.
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suggesting that OPA3 plays a role in mitochondrial fission and
links this process to optic atrophy (340).
Another protein involved in mitochondrial morphology is
mitochondrial fission process protein 1 (MTFP1). Knock-
down of MTFP1 inhibited DRP1-mediated mitochondrial
fission, leading to mitochondrial hyperfusion (386, 387, 407).
Translation of MTFP1, and thereby the mitochondrial re-
cruitment of DRP1, is regulated by the nutrient-sensing com-
plex mechanistic/mammalian target of rapamycin complex 1
(270). This mechanism provides a link between environmen-
tal/intracellular stimuli and mitochondrial morphofunction.
With respect to calcium homeostasis, mitochondria can un-
dergo ‘‘mitochondrial shape transition’’ (MiST), which is
distinct from mitochondrial fission/swelling and mediated by
the mitochondrial Rho GTPase 1 (MIRO1) (280). MiST was
induced by increased calcium levels in the cytosol, but not by
mitochondrial calcium uptake by the mitochondrial calcium
uniporter (MCU). It was further demonstrated that autophagy/
mitophagy induction requires MIRO1-dependent MiST.
F. Secondary functions of mitochondrial fission
and fusion proteins
It is often overlooked that mitochondrial fission/fusion
proteins also exert important ‘‘secondary’’ functions in cell
physiology (412). For instance, the Mfn2 gene is also known
as Hsg (hyperplasia suppressor gene) and is involved in the
control of cell proliferation and apoptosis. The MFN2 protein
exerts its antiproliferative effect by inhibiting the RAS-RAF-
ERK signaling cascade by N-terminally interacting with
RAF-1 and C-terminally with RAF (55). In brown adipose
tissue (BAT), MFN2 was involved in the docking of mito-
chondria to LDs, allowing efficient FA transfer to mito-
chondria for b-oxidation (37). In mice, MFN2 in BAT was
required for cold-induced thermogenesis and promoted in-
sulin resistance in obese animals (240). On dysfunctional
mitochondria, MFN2 can also act as a Parkin-receptor, an E3
ubiquitin ligase implicated in Parkinson’s disease (57). Me-
chanistically, it was proposed that mitochondrial Dw depo-
larization leads to stabilization of PTEN-induced putative
kinase 1 (PINK1) at the MOM. After this stabilization,
PINK1 phosphorylates MFN2, thereby increasing the bind-
ing of Parkin to stimulate mitophagy. In this way, absence of
MFN2 interrupted the PINK1-Parkin mitochondrial quality
control mechanism, leading to accumulation of dysfunctional
mitochondria (57). In addition to the pathway just described,
there is considerable additional crosstalk between mito-
chondrial fusion and Parkin-mediated mitophagy (92, 382).
Evidence in adipocytes suggests that OPA1 also can reside
outside mitochondria on LDs to act as an A-kinase anchoring
protein (313). It was proposed that OPA1 is involved in li-
polysis of neutral lipids stored in the LDs. However, this
mechanism is still controversial (23).
Other ‘‘secondary’’ functions of mitochondrial fission/
fusion proteins include (Table 1): (i) execution of peroxisome
fission (DRP1, FIS1, MFF) (181, 353, 354), (ii) MOM protein
distribution (MFNs) (418), (iii) ER morphology regulation
and ER-mitochondria interactions (MFN2) (77, 102), (iv) the
unfolded protein response (MFN2) (272), (v) apoptosis
(DRP1, FIS1, OPA1) (108, 378, 416), (vi) metabolic regu-
lation (MFN1, MFN2) (86, 312), (vii) cell cycle and division
FIG. 10. Role of OPA1, the MICOS complex and CV in cristae shaping. (A) Tightening of cristae by OPA1 oligomers.
See main text for details. (B) Structural shaping of the MIM by the MICOS complex and CV (arrow indicates potential
interactions). Additional MICOS complex subunits (MICs) and further details are presented in the main text and Sup-
plementary Table. This figure was compiled by integrating information from (238, 308, 327, 427). ATAD3A, MIM ATPase;
CV, OXPHOS (oxidative phosphorylation) complex V; L-OPA1, long form of OPA1; MIC10, MICOS complex subunit 10;
MIC12, MICOS complex subunit 12; MIC19, MICOS complex subunit 19 (or CHCHD3); MIC26, MICOS complex subunit
26; MIC27, MICOS complex subunit 27; MIC60, MICOS complex subunit 60 (or Mitofilin, IMMT); MICOS, mito-
chondrial contact site and cristae organization; S-OPA1, short form of OPA1; SAM, protein sorting and assembly ma-
chinery; TOM, protein translocase of the MOM. Color images are available online.
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(hFIS1, OPA1, MFN1) (208), (viii) mPTP opening (hFIS1,
DRP1) (184), (ix) endocytosis (DRP1) (217), (x) calcium
homeostasis (MFN2, DRP1) (54, 77, 102, 378), (xi) antiviral
signaling (MFN2) (433), (xii) melanosome biogenesis
(MFN2) (73), and (xiii) cell senescence (hFIS1, OPA1) (207).
This multi-functionality is possibly responsible for apparent
discrepancies in experimental results between various studies.
For example, stimulation of mitochondrial fusion in Droso-
phila dramatically reduced ROS levels (276), whereas stimu-
lation of mitochondrial fission suppressed oxidative damage in
murine postmitotic neurons (168). This means that similar
alterations in mitochondrial morphology (e.g., fragmentation
or filamentation; Fig. 7B, C) can serve a different purpose
depending on the cell type, upstream signaling pathway,
metabolic state, and physiological context. Obviously, the
‘‘secondary’’ functions of mitochondrial fission and fusion
proteins need to be taken into account for proper interpretation
of experimental results.
III. Regulation of Mitochondrial (Ultra)Structure
The regulation of mitochondrial morphology is a subject of
intense study. This control is primarily exerted by modifying
the function of mitochondrial fission and fusion proteins at
various levels. This includes microRNAs (Supplementary
Table), which act as negative regulators of gene expres-
sion by inhibiting mRNA translation or promoting mRNA
degradation (205). Here, we focus on the role of post-
translational modifications (PTMs) and mitochondrial lipids.
A. Regulation by post-translationlal modifications
of fission and fusion proteins
Mitochondrial fission and fusion proteins contain various
(predicted) PTM sites, allowing their phosphorylation, S-
nitrosilation, sumoylation, ubiquitination, tyrosine sulfation,
acetylation, and S-palmitoylation (5, 70, 279, 425). Depending
on the nature and location of the PTM, either mitochondrial
fission or fusion is stimulated (51, 103, 289). These mecha-
nisms are explained in more detail below (sections III.A.1–12).
1. Stimulating fission by DRP1 phosphorylation at S616
(human isoform 1). S616 corresponds to S579 in rats and
mice. In mitotic cells and neurons, DRP1 phosphorylation at
S616 is stimulated by cyclin-dependent kinases (CDKs) (63,
375, 380) and protein kinase Cd (319). This phosphorylation
stimulates DRP1 activity and mitochondrial fission. To the
best of our knowledge, no phosphatases are currently de-
scribed for this phosphorylation site. Mammalian DRP1
genes include three alternative exons and evidence was
provided that alternative splicing generates a cytoskeletal
DRP1 ‘‘reserve pool,’’ which translocates to the MOM on
CDK-induced phosphorylation (375). This means that alter-
native splicing and phosphorylation might function as an
isoform-specific mechanism that (co)controls DRP1 subcel-
lular localization and mitochondrial fission. Remarkably,
S616 phosphorylation by CDK5 inhibited DRP1, thereby
contributing to mitochondrial elongation during neuronal
maturation under physiological conditions (63). It was pro-
posed that CDK5 reduces the oligomerization activity of
DRP1.
2. Stimulating fission by DRP1 phosphorylation at S585.
Analysis of a mouse model revealed that neuronal injury
induced by N-methyl-D-aspartate was associated with DRP1
phosphorylation by CDK5 at S585 and mitochondrial fission
(156).
3. Stimulating fission by DRP1 SUMOylation. SUMO
(small ubiquitin-like modifier) proteins are attached to lysine
residues of other proteins by the combined action of an E1
complex, a single E2, ubiquitin carrier protein 9, and several
E3 enzymes (424). SUMOylation of DRP1 potentially
stimulates its oligomerization at the MOM, leading to in-
creased mitochondrial fission (416).
4. Stimulating fission by DRP1 glycosylation. In mouse
cardiomyocytes, pharmacological inhibition of N-acetyl-
glucosaminidase (OGA), which removes O-GlcNAc residues
from Thr and Ser residues, resulted in increased O-linked-N-
‰
FIG. 11. Mitochondrial morphofunctional heterogeneity. (A) Summarizing scheme for simultaneous quantification of
mitochondrial free ATP levels, membrane potential (Dw), and mitochondrial morphology by single-cell fluorescence
microscopy. Bold symbols (i.e., B, C, D, E, F, G, N) refer to the corresponding panels to the right. PHSFs (control CT5120)
were transfected with a mitochondria-targeted variant of ‘‘ATeam’’ (Cox8-ATeam 1.03 or ‘‘MitoATeam’’), an ATP-sensing
CFP/YFP-based FRET (fluorescence resonance energy transfer) reporter molecule (150, 218). The YFP/CFP emission ratio
of ATeam can be used as a measure of free ATP concentration. Subsequently, MitoATeam-expressing cells were stained
with TMRM (that accumulates in mitochondria in a Dw-dependent fashion). Next, the acquired images were processed and
quantified to assess ATeam and TMRM signals for individual mitochondria and to allow multiparameter analysis. (B)
Background-corrected (COR) image depicting the ATeam YFP signal. (C) Binarized (black-and-white; BIN) version of (B)
obtained after image processing (explained in Fig. 13). (D) Version of the YFP-BIN image in which non-mitochondrial
objects with an area <10 pixels (noise pixels) were removed by thresholding. (E) Masked (MSK) version of (B) obtained by
applying a Boolean AND operation to the YFP-COR (B) and YFP-BIN image (C). (F) Same as (E), but now for the CFP-
COR (not shown) and YFP-BIN image (C). (G) Same as (E), but now for the TMRM-COR (not shown) and YFP-BIN
image (C). (H) ATeam ratio image obtained by dividing the YFP-MSK image (E) by the CFP-MSK image (F). To allow
visualization, the ATeam ratio value for each pixel was multiplied by the number 20. (I) Colorized version of (F). Pixels
were colorized according to their ratio value (blue = low; red = high). (J) Same as (I), but now for (G). (K) Magnification of
the region in (H) depicting individual mitochondria. (L) Same as (K), but now showing a magnification of (I). (M) Same as
(K), but now showing a magnification of (J). (N) 3D scatter plot of the ATeam ratio signal versus mitochondrial TMRM
signal versus mitochondrial size (area) of the mitochondrial objects in (M). Each dot represents an individual mitochondrial
object. Color images are available online.
2080 BULTHUIS ET AL.
2081
acetyl-glucosamine glycosylation of DRP1 at T585 and T586
(and possibly also S616 and S637) (115). Increased DRP1
glycosylation enhances GTP binding and MOM recruitment
of this protein, paralleled by mitochondrial fragmentation
andDw depolarization. Evidence was provided that increased
O-GlcNAcylation decreases the phosphorylation of DRP1 at
S637, compatible with stimulation of mitochondrial fission.
5. Stimulating fission by MFF phosphorylation at S155
and S172. MFF phosphorylation at S155 and S172 is me-
diated by AMP-activated protein kinase A (AMPK). This
phosporylation stimulates mitochondrial fission by promot-
ing DRP1 recruitment to the MOM (388).
6. Stimulating fission by MFN1 phosphorylation. ERK2
or MAPK1-mediated MFN1 phosphorylation inhibits
MFN1 oligomerization, thereby stimulating mitochondrial
fission (318).
7. Stimulating fission by MFN1 acetylation. MFN1
acetylation triggers its degradation via ubiquitination
mediated by membrane-associated ring finger (C3HC4) 5
(MARCH5 or MITOL), thereby stimulating mitochondrial
fission (304).
8. Stimulating fission by MFN2 phosphorylation at S27.
During stress conditions (e.g., treatment with doxorubicin,
cis-platinum, or tunicamycin), MFN2 is phosphorylated at
S27 by c-JUN N-terminal kinase ( JNK), which leads to re-
cruitment of the ubiquitin ligase (E3) HUWE1/MULR/ARF-
BP1/HECTH9/E3Histone/LASU1 to MFN2 (204). As a
consequence, MFN2 is ubiquitinated and subsequently de-
graded, leading to mitochondrial fragmentation and en-
hanced AC death.
9. Stimulating fusion by DRP1 ubiquitination. Poly-
ubiquitination of DRP1 leads to its degradation and is pro-
moted by MARCH5 (278), the cytosolic E3 ubiquitin ligase
Parkin (413), and anaphase-promoting complex/cyclosome
and its coactivator CDH1 (APC/CCDH1) E3 ubiquitin ligase
complex (144). MARCH5 is an integral MOM protein that
interacts with ubiquitinated DRP1 and its overexpression
stimulates mitochondrial filamentation (278). Parkin interacts
with and ubiquitinates DRP1 to stimulate its proteasome-
dependent degradation (413). During cell division, changes in
mitochondrial morphology involve APC/CCDH1-driven
DRP1 ubiquitination and its subsequent proteasomal degra-
dation. Inhibition of this process prevents normal G1 phase
regrowth of mitochondrial networks after cell division (144).
10. Stimulating fusion by DRP1 phosphorylation at S637
(human isoform 1). S637 corresponds to S656 (in rat) and
S600 (in mouse). This phosphorylation is stimulated by: (i)
the proto-oncogene PIM1 (88), (ii) protein kinase A/A kinase
anchor protein 1 (PKA/AKAP1) (52, 71), (iii) the rho-
associated coiled coil-containing protein kinase 1 (ROCK1)
(415), and (iv) calcium/calmodulin-dependent kinase 1a
(CAMK1a) (136). The functional role of S637 phosphory-
lation is somewhat enigmatic. Under conditions of simulated
ischemia, PIM1-induced S637 phosphorylation preserved
mitochondrial filamentation by preventing DRP1 transloca-
tion to the MOM (88). Compatible with this result, PKA-
induced phosphorylation of S637 decreased DRP1 GTPase
activity (52, 71). In contrast, ROCK1-induced S637 phos-
phorylation stimulated DRP1 translocation to the MOM in a
hyperglycemic mouse model (415). Similarly, Ca2+ influx
through voltage-operated calcium channels blocked mito-
chondrial movement and stimulated CAMK1a-mediated
S637 phosphorylation, associated with increased DRP1 re-
cruitment to the MOM and mitochondrial fission in neurons
(136). It was proposed that the functional consequences
of S637 phosphorylation might be highly cell type and/or
stimulus dependent (415).
Dephosphorylation of S637 involves: (i) phosphoglycerate
mutase family member 5 (171), (ii) protein phosphatase 2A/
Bb2 (PP2A/Bb2) (82), and (iii) calcineurin (CaN) (71). For
these phosphatases, S637 dephosphorylation was associated
with a stimulation of mitochondrial fission. Translocation of
PPA2/Bb2 to the MOM is regulated by its N-terminal
phosphorylation (257). The Bb2 regulatory subunit targets
the scaffolding (A) and catalytic (C) subunits of PP2A to the
MOM via transient association with receptor components of
the TOM complex (426). In addition to PKA, AKAP1 also
recruits other signaling enzymes to the MOM, including
protein phosphatase 1 and CaN (426). Inducers of Dw de-
polarization trigger Ca2+/CaN-dependent S637 dephosphor-
ylation, which stimulates DRP1 translocation to the MOM
and mitochondrial fission (49). Interestingly, it was recently
demonstrated in mouse cells and brain lysates that the levels
of S637-phosphorylated DRP1 displayed a 24-h rhythm.
This was paralleled by rhythmic stimulation of mitochon-
drial fusion and circadian ATP production (349). This
suggests that oxidative metabolism is regulated by the cir-
cadian rhythm in non-dividing cells mediated by cyclic
DRP1 phosphorylation and inactivation.
11. Redox-dependent PTMs. Especially during patho-
logical conditions, mitochondria are considered significant
intracellular sources of ROS, which can not only potentially
damage biomolecules but also play crucial signaling roles
(188, 241, 357). Also, mitochondrial fission and fusion pro-
teins constitute targets of various redox pathways, thereby
FIG. 12. Mitochondrial ultrastructural parameters re-
lated to mitochondrial function. Various quantitative param-
eters of mitochondrial ultrastructure affecting mitochondrial
bioreactions. This figure was created by using information from
(403). Color images are available online.
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allowing regulation of mitochondrial morphology (425):
(i) nitration of Paraplegin and PKA/AKAP1 (potentially
affecting DRP1/MFN2 activity and OPA1 processing); (ii) S-
nitrosylation of DRP1 at C644 (potentially increasing its
activity), OPA1 (potentially affecting its activity), Caspase 3
(inhibiting OPA1 processing), CDK5 (inhibiting DRP1 ac-
tivity), Parkin (stimulating DRP1 and MFN2 activity), and
JNK (stimulating MFN2 activity); (iii) disulfide bond al-
terations in amyloid-b (stimulating DRP1 activity), PKA/
AKAP1 (inhibiting DRP1 activity), TIMM8A (potentially
affecting DRP1 activity), and ROMO1 (stimulating OPA1
cleavage); and (iv) ROS-induced Dw depolarization stim-
ulating hydroxyl radical production, lipid peroxidation,
protein carbonylation, and OPA1 cleavage.
Disulfide bond-mediated crosslinking between MFNs in
a glutathione and GTP-dependent manner might contribute
to mitochondrial hyperfusion that protects against oxidative
stress (364). This protection might be exerted by sharing
ROS-induced damage and/or mitochondrial antioxidants
between individual mitochondria by stimulating fusion
between ‘‘damaged’’ and ‘‘healthy’’ organelles (281). Re-
cently, it was demonstrated that protein disulfide isomerase
A1 (PDIA1) can function as a DRP1 thiol reductase (176).
PDIA1 depletion stimulates DRP1 sulfenylation, thereby
stimulating mitochondrial fragmentation.
12. Other PTMs. In case of MFN2, evidence was pro-
vided that its Parkin-mediated ubiquitination depends on
phosphorylation of MFN2 residues T111/S442 by the mito-
chondrial kinase PINK1 (57). The same study demonstrated
that MFN2 ablation prevents Parkin translocation to the
MOM and suppresses mitophagy in mouse cardiac myocytes
during Dw depolarization. S442 can also be phosphorylated
by PKA but this appears to play a role in MFN2-mediated
suppression of vascular smooth muscle cell growth inde-
pendent of mitochondrial morphology (446). MARCH5
binds and ubiquitinates mitochondrial MFN2 but not ER-
associated MFN2, thereby regulating ER tethering to mito-
chondria by activating MFN2 via K192 ubiquitination (377).
Polyubiquitinated MFN2 is then activated, leading to an in-
crease in GTP-binding ability and is associated with the ER-
localized MFN2, resulting in the oligomerization of MFN2
and attachment of mitochondria to the ER (277).
Evidence in yeast demonstrated the existence of two in-
dependent pathways for activation and degradation of MFNs
to control MOM fusion (9, 423). In this mechanism, MOM
fusion is activated by addition of stabilizing ubiquitin chains
to MFN by an E3 ubiquitin ligase. Removal of these chains by
a deubiquitylase (UBP12) then impairs MOM fusion and
promotes mitochondrial fragmentation. In contrast, another
E3 ligase attaches destabilizing ubiquitin chains to MFN,
which are removed by a different deubiquitylase (UBP2) to
support outer membrane fusion.
B. Role of mitochondrial lipids in mitochondrial
(ultra)structure
Mitochondria display a distinct lipid composition when
compared with other cell constituents (ER, PM, Golgi, and
late endosomes) (399). More specifically, the MOM and
MIM display a high content of non-bilayer phospholipids
such as cardiolipin (CL) and phosphatidylethanolamine (PE)
(384). Lipidomics analysis of mouse liver mitochondria re-
vealed the following lipid composition: 25% PC (phospha-
tidylcholine), 18% CL, 14% PE, 10% phosphatidylglycerol,
10% phosphatidylinositol, 6% phosphatidylserine, 5% lyso-
phosphatidylethanolamine, 5% sphingomyelin, 3% CER
(ceramide), 3% lysocardiolipin, and 2% PA (phosphatidic
acid) (13). In yeast, the MIM displayed a higher CL content
than the MOM, whereas CL was virtually absent from the ER
membrane (384). Mitochondrial membrane lipids are deliv-
ered by the ER or synthesized within mitochondria from ER-
derived precursor lipids (347, 384). Inside the mitochondrion,
phospholipids can be transported between the MIM and
MOM and also be exchanged with the ER membrane. For
instance, the lipid transfer protein STARD7 shuttles PC from
the MOM to the MIM (342).
Various lipid-mediated signaling mechanisms are in-
volved in the regulation of mitochondrial function. Examples
include (254, 287): (i) mitophagy, where CL translocates
from the MIM to the MOM to bind LC3 and LC3-B-II in
collaboration with CER to induce autophagosomal mitochon-
drial recruitment; (ii) ETC assembly, where the chaperone
PHB2 involved in CIV assembly interacts with sphingosine-1-
phosphate (S1P); and (iii) apoptosis, where CER accumulates
and acts together with Bax to induce pore formation, allowing
cytochrome-c exit and apoptosis activation.
With respect to mitochondrial function, CL is the best
studied mitochondrial lipid. CL has a dimeric structure,
consists of four acyl chains and two phosphate groups, and
plays a role in mitochondrial cristae organization. The latter
is probably linked to the observation that the curvature of the
MIM induces an asymmetric distribution of CL and PE (these
segregate into the negatively curved monolayer leaflet facing
the crista lumen) versus PC (this segregates into the posi-
tively curved monolayer leaflet facing the mitochondrial
matrix (149). On CL incorporation, membrane bilayer de-
formability increases and CL becomes enriched in regions
with a highly negative curvature (38).
Interestingly, specific proteins have been described that
sense membrane curvature (membrane curvature sensing or
MCS proteins) via their amphipathic helices (AHs) and Bin/
Amphiphysin/Rcs BAR domains (239). Mechanistically, it
was proposed that AHs detect and fill up lipid packing defects
by inserting their hydrophobic part whereas BAR domains
sense membrane curvature via electrostatic interactions
(239). It is tempting to speculate that (CL-induced) changes in
MIM curvature affect the stability and/or activity of integral
membrane proteins (IMPs). Such an IMP-stabilizing effect
might also be linked to the established role of CL in mito-
chondrial protein transport, MCU-mediated mitochondrial
calcium uptake, and ETC functioning (35, 93). Indeed, CL-
induced IMP stabilization has been described for individual
ETC complexes in bovine and yeast as well as ETC super-
complexes and uncoupling protein 1 (274). Studying isolated
CI revealed that its catalytic activity strongly depends on the
phospholipid content of the preparation (359). CL was bound to
CI, possibly playing a stabilizing role, and CI catalytic activity
was influenced by binding of PE and PC to the complex (359).
Mitochondrial lipids have also been implicated in the
regulation of mitochondrial (ultra)structure (131). CL and PA
coordinate mitochondrial dynamics by interacting with
DRP1, MFN, and OPA1 (16, 170). Using cryo-EM analysis
of DRP1 on nanotubes with a distinct lipid composition,
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evidence was provided that DRP1-CL interactions activate
DRP1 oligomers (106). These authors further suggested that
MIM-to-MOM translocation of CL enhances mitochondrial
fission. PA inhibits DRP1 activity (2, 174, 405). A mito-
chondrial phospholipase D (mitoPLD) was detected on the
MOM to promote transmitochondrial membrane adherence
by a mechanism that was MFN-dependent and involved CL
hydrolysis to form PA (64). It was suggested that PA could
play the following roles during mitochondrial fusion: (i) to
stimulate opposing membrane fusion by generating negative
membrane curvature, (ii) to recruit additional biomolecules
involved in fusion, and (iii) to be converted in another fu-
sogenic lipid. A later study suggested that a PA-preferring
phospholipase A1 (PA-PLA1) plays a regulatory role in mi-
tochondrial morphology regulation since its overexpression
and knockdown induced mitochondrial fragmentation and
elongation, respectively (14). In this mechanism, increased
PA-PLA1 activity (which leads to lower PA levels to inhibit
mitochondrial fusion) counterbalances mitoPLD activity (which
increases PA levels to stimulate mitochondrial fusion).
Evidence in a fly model and mammalian cells revealed that
loss of mitoguardin (MIGA) induces mitochondrial frag-
mentation via its interaction with mitoPLD (443). This study
provided evidence that MIGA functions downstream of MFN
by stabilizing mitoPLD and stimulating MFN dimerization.
Also, PE appears to play a role in this process since a mod-
erate reduction (<30%) in mitochondrial PE levels induced
mitochondrial fragmentation, impairment of mitochondrial
function and reduced cell growth (383). Similarly, a role for
lysophosphatidic acid (LPA) was proposed in mitochondrial
fusion (292). This study revealed that mitochondrial GPAT
(glycerol-3-phosphate acyltransferase; mitoGPAT) catalyzes
the initial and rate-limiting step in LPA synthesis. Analyses
in Caenorhabditis elegans and mammalian cells demon-
strated that mitoGPAT depletion induced mitochondrial
fragmentation, which was rescued by LPA. This suggests that
mitoGPAT-mediated LPA-formation plays a role in mito-
chondrial fusion (292).
IV. The Concept of Mitochondrial Morphofunction
Changes in mitochondrial (ultra)structure and function are
bidirectionally linked in many ways, and there are numerous
studies in which (ultra)structural modulation induces func-
tional changes and vice versa. The strong coupling between
mitochondrial (internal) structure and function suggests that
they are equivalent, thereby giving rise to the concept of
mitochondrial ‘‘morphofunction.’’ This term was first pro-
posed by Benard and Rossignol (24) when they defined
‘‘mitochondrial morphofunctional analysis’’ as: ‘‘the simul-
taneous quantification of mitochondrial morphological and
functional readouts.’’ Later, we illustrate the importance of
the mitochondrial morphofunctional concept by presenting
results obtained in knockout (KO) animals and patients with
mutations in mitochondrial fission/fusion proteins. Next, we
discuss various other experimental studies that highlight the
bidirectional link between mitochondrial (ultra)structure and
function. Finally, we briefly summarize how mitochondrial
morphofunction can be quantified in living cells, how mito-
chondrial (ultra)structure links to mitochondrial bioreact-
ions, and how mitochondrial morphology can be targeted by
small molecules.
A. Studies in knockout animals
Animal models have delivered valuable insights into the
physiological and functional role of fission and fusion pro-
teins. For instance, Drp1 gene KO mice display develop-
mental abnormalities, particularly in the forebrain, and die
after embryonic day 12.5 (152). The same study revealed that
neural cell-specific Drp1-null animals die shortly after birth
due to brain hypoplasia and apoptosis. Compatible with the
dual role of DRP1 in mitochondrial and peroxisomal fission
(see section III and Table 1), Drp1-null cells contain exten-
sive mitochondrial networks and elongated peroxisomes,
although a reduction in cellular ATP level was not detected
(408). In postmitotic Purkinje cells of mouse cerebellum,
Drp1 deletion induced mitochondrial elongation followed by
formation of large spherical mitochondria due to oxidative
stress (168). These mitochondrial spheres lost respiratory
function, and accumulated ubiquitin and markers of mito-
phagy, leading to neurodegeneration. It was concluded that
fission of mitochondria prevents oxidative damage, thereby
contributing to neuronal survival. This is compatible with the
idea presented earlier that fusion of individual mitochondria
allows sharing of ROS-induced damage and/or antioxidants
within the mitochondrial population (281).
MFN1 and MFN2 are of key importance for proper embry-
onic development, and KO mice die before mid-gestation (56).
Loss of Mfn2 resulted in progressive, retrograde degeneration
of dopaminergic neurons in the nigrostriatal circuit (310). The
current experimental evidence in various pathological models
suggests that increased levels of L-OPA1 are protective (238).
Such a protection was induced by Oma1 KO (198, 429), in-
creased OMA1 degradation (432), or OPA1 overexpression
(400). Compatible with the latter, increased L-OPA1 proces-
sing was not detected during OPA1 overexpression associated
with (mild) improvement of mitochondrial disease phenotypes
in (CI-deficient) Ndufs4 KO mice and (CIV-deficient) Cox15
muscle-specific KO mice (66). In adult cardiomyocyte-specific
Yme1l KO mice, L-OPA1-mediated mitochondrial fusion was
required to preserve cardiac function whereas stress-induced
OMA1-mediated processing of L-OPA1 and accompanying
mitochondrial fragmentation induced dilated cardiomyopa-
thy and heart failure (406). In this sense, Oma1 gene dele-
tion and normalization of mitochondrial structure protected
against cell death and heart failure. Interestingly, mitochon-
drial fragmentation triggered a switch in metabolism from FA
to glucose utilization and reversing this switch preserved
normal heart function even though mitochondrial fragmen-
tation was not normalized (406). This demonstrates that in the
absence of YME1L, heart function can be restored by pre-
venting OMA1-mediated L-OPA1 processing and restoring
mitochondrial morphology, or by normalizing metabolism
that bypasses the deleterious effects of altered mitochondrial
morphology on heart metabolic function (406).
B. Patients carrying mutations in mitochondrial fission
and fusion proteins
Mutations in mitochondrial fission/fusion proteins induce
human disease (11). This includes congenital microcephaly,
lactic acidosis and sudden death (DRP1) (417), Leigh-like
encephalopathy, optic atrophy and peripheral neuropathy
(MFF) (182), Charcot-Marie-Tooth neuropathy type 2A
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(MFN2) (450), and optic atrophy (OPA1) (4). In addition,
various alterations in mitochondrial fission and fusion pro-
teins were demonstrated in experimental models of neuro-
degeneration (103, 180): (i) The levels/activity of DRP1
and mitochondrial fission were increased in a rat model of
amyotrophic lateral sclerosis (various gene mutations), a
mouse model of Alzheimer’s disease (AD; various gene
mutations), and human/mouse/rat models of Huntington’s
disease (HD; Huntingtin mutation); (ii) the levels/activity of
DRP1 and mitochondrial fission were decreased in human
and mouse models of autosomal-recessive spastic ataxia of
Charlevoix-Sanguenay disease (SACS/Sacs gene mutation);
(iii) the levels/activity of ganglioside-induced differentiation-
associated protein 1 (GDAP1) and mitochondrial fission were
reduced in human models of autosomal dominant Charcot–
Marie–Tooth disease, axonal (CMT2K; GDAP1 gene muta-
tion), autosomal recessive Charcot–Marie–Tooth disease,
axonal, type 2K (ARCMT2K; GDAP1 gene mutation), and
autosomal recessive Charcot–Marie–Tooth disease, type 4A,
demyelinating (CMT4A; GDAP1 gene mutation); (iv) the
levels/activity of MFN2 and mitochondrial fusion were re-
duced in human and rat models of autosomal dominant
Charcot–Marie–Tooth disease, axonal, type 2A2 (CMT2A2;
MFN2/Mfn2 gene mutation); and (v) the levels/activity of
OPA1 and mitochondrial fusion were reduced in human and
rat models of autosomal dominant optic atrophy (OPA1/
Opa1 gene mutation).
With respect to CMT2A2, the consequences of its muta-
tions on MFN2 activity and neuronal function were recently
investigated in a Drosophila fly model (96). Analysis of four
pathological mutations (R94Q, R364W, T105M, and L76P)
revealed that they all increased mtDNA mutations, decreased
oxidative metabolism, and induced mitochondrial depletion
at neuromuscular junctions. R94Q and T105M mutations
induced aggregation of nonfused mitochondria and their
loss of function. Remarkably, R364W and L76P mutations
stimulated mitochondrial fusion. It was proposed that both
excessive mitochondrial aggregation and fusion can underlie
CMT2A pathophysiology (96). Changes in mitochondrial
(ultra)structure and mitochondrial function have also been
described in human aging (356) as well as in a plethora of other
human pathologies, including: (i) Parkinson’s disease (339),
(ii) AD (126), (iii) HD (130), (iv) ischemia/reperfusion injury
(215), (v) mitochondrial metabolic disorders (196), (vi) car-
diac disease (92), (vii) kidney disease (27), (viii) cell starvation
(325), (ix) diabetes (336), (x) cancer (390), (xi) sepsis (122),
and (xii) the effects of environmental toxins (163).
C. Bidirectional links between mitochondrial
(ultra)structure and function
Next, we further elaborate on the concept of mitochondrial
morphofunction by presenting experimental evidence dem-
onstrating that: (i) mitochondrial (ultra)structure affects mi-
tochondrial function, (ii) mitochondrial function affects
mitochondrial (ultra)structure, (iii) mitochondrial internal
structure affects mitochondrial external structure, (iv) mito-
chondrial external structure affects mitochondrial internal
structure, (v) mitochondrial morphofunction affects cell
function, and (vi) cell function affects mitochondrial mor-
phofunction.
1. Mitochondrial (ultra)structure affects mitochondrial
function. It is firmly established that MIM dynamics and
topology impact on mitochondrial bioenergetics (244, 306–
308). For instance, changes in mitochondrial morphology and
organization can enhance energy supply from OXPHOS in
diabetic cardiomyopathy (159). Analysis of heteroplasmic
human rhabdomyosarcoma cells harboring the pathological
A3243G mtDNA mutation, associated with the neuro-
muscular syndrome MELAS (mitochondrial encephalomyo-
pathy, lactic acidosis, and stroke-like episodes), revealed that
knockdown of DRP1 or FIS1 leads to increased levels of
mutated mtDNA (242). This increase was not observed on
knockdown of OPA1, suggesting that OPA1-dependent MIM
fission and cristae organization are not involved in segregation
of mutant and wild-type mtDNA (242). Supporting these re-
sults, MFN-mediated mitochondrial fusion protected against
neurodegeneration in the cerebellum (58) and was required for
mtDNA stability and tolerance of mtDNA mutations in skel-
etal muscle (59). MFN2-induced mitochondrial elongation
protects against ROS-induced mPTP opening and represses
staurosporin-induced BAX and cytochrome-c release (281).
During starvation-induced autophagy, the MOM partici-
pates in autophagosome formation by supplying membranes
(134) and DRP1 was phosphorylated in a cAMP/PKA-
dependent manner (120). This prevented DRP1 translocation
to the MOM and induced formation of elongated mitochon-
dria, which maintained their ATP production, contained more
cristae, displayed increased CV levels/activity, and were not
undergoing mitophagy. As a consequence, these elongated
mitochondria were protected from autophagosomal degra-
dation (326). Similarly, DRP1 knockdown and mitochondrial
elongation protected melanoma cells from mitophagy-
mediated death induced by CI inhibition (20).
Using a cell starvation model, evidence was provided that
the autophagic process provides FAs for LDs, which transfer
into mitochondria only if the latter have a tubulated mor-
phology (325). This mechanism, which also required LD li-
polysis, allows cells to survive during starvation by shifting
their metabolism toward FA oxidation (409). Later studies
argued that LDs are not required for FA delivery to mito-
chondria but instead function to prevent acylcarnitine accu-
mulation and lipotoxic dysregulation of mitochondria (283).
Further, a DRP1-independent mitophagy pathway was de-
scribed (430). In this respect, inhibition and stimulation of
the autophagy pathway were associated with increased and de-
creased DRP1 levels, respectively, suggesting that DRP1 is tar-
geted by the autophagy process for lysosomal degradation (317).
Interestingly, both mitochondrial hyperfusion and hyper-
fragmentation protected cells against BAX-mediated apo-
ptosis induction, suggesting that BAX requires a distinct
mitochondrial shape to induce mitochondrial outer membrane
permeabilization (330). The latter study proposed three fac-
tors that regulate BAX-mediated apoptosis: (i) a combination
of stress-specific BH3-only proteins that induce apoptosis, (ii)
an MOM composition that is regulated by lipid metabolic
pathways, and (iii) a distinct net mitochondrial morphology
resulting from the combined action of mitochondrial dy-
namics proteins that allows proper BAX integration and pore
formation. In this sense, the large variety in mitochon-
drial morphology observed using different cell types and
(patho)physiological conditions suggests that this structural
diversity contributes to the differences in apoptosis sensitivity
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in these systems (330). The mitochondrial content of cells
depends on cell size (177) and impacts mitochondrial function
(259). In this context, single-cell analysis revealed that mito-
chondrial content affects the level of apoptotic proteins and thus
cell sensitivity to apoptotic stimuli, meaning that cells with more
mitochondria were more prone to cell death induction (246).
2. Mitochondrial function affects mitochondrial (ultra)
structure. Mitochondrial Dw regulates the configuration of
the mitochondrial matrix and cytochrome-c release during
apoptosis (123). Classical studies revealed that alterations in
mitochondrial functional state, as typically observed in a
wide range of (patho)physiological conditions and human
diseases, are not only associated with altered mitochondrial
dynamics but also affect the ultrastructure of the MIM. In
response to low ADP concentrations, the structure of the
MIM changed from a condition in which the mitochondrial
matrix was contracted and dense (the ‘‘condensed state’’), to
a less dense and more expanded state (‘‘orthodox’’), associ-
ated with a more compact cristae compartment (132).
Inactivation of OPA1 by proteolytic cleavage mediated by
OMA1 and YME1L is induced during cellular stress, leading
to stimulation of mitochondrial fission (238). OPA1 cleavage
also depends on mitochondrial ATP levels and bivalent
metals (18). Both OMA1 and YME1L are activated by Dw
depolarization, thereby inducing OPA1 cleavage, mitochon-
drial fragmentation, and removal of damaged mitochondria
by mitophagy (138, 238, 441). Inhibitory OMA1-mediated
processing of OPA1 is also stimulated by knockdown of the
m-AAA proteases AFG3L1 and AFG3L2 (95). Moreover,
in the absence of the MIM PHB2, L-OPA1 is lost and mi-
tochondrial fusion is defective (256). An MIM-specific ef-
fect on OPA1 cleavage was demonstrated in cells from
patients with mtDNA mutations. This effect was mediated by
YME1L, which cleaved OPA1 more efficiently under con-
ditions at which OXPHOS activity was high (265). When Dw
drops below a certain threshold, DRP1-induced mitochon-
drial fission and OMA1-mediated cleavage of OPA1 are ac-
tivated (165). OPA1 processing mediated by YME1L was
modulated by Dw, and OPA1 isoforms interact with MFN1
and MFN2 in a Dw-independent manner (129). In combina-
tion with cellular ATP depletion, Dw depolarization is par-
alleled by OMA1 activation and YME1L degradation (324).
This differential degradation of OMA1 and YME1L affects
the proteolytic processing of OPA1, which might allow cells
to adjust mitochondrial morphology and function to different
types of stress (324). Evidence was provided that Dw-
dependent processing of OPA1 impacts mitochondrial func-
tion (152, 294). In mouse muscle, age-associated loss of
OPA1 can activate a signaling cascade starting from the ER
that systemically affects metabolism and aging (385).
3. Mitochondrial internal structure affects mitochondrial
external structure. A recent study in neuronal cells dem-
onstrated that spontaneous and repetitive constrictions of
the mitochondrial inner compartment (CoMIC) were closely
associated with subsequent division of the mitochondrion
(62). CoMIC was stimulated by increased matrix Ca2+ levels,
mitoKCa-mediated ultrastructural changes, and Dw depolar-
ization and OMA1-catalyzed accumulation of S-OPA1,
suggesting that these intra-mitochondrial constrictions prime
mitochondrial division.
4. Mitochondrial external structure affects mitochondrial
internal structure. Interestingly, cristae remodeling during
apoptosis requires mitochondrial fission mediated by DRP1,
MIEF1/MID51, and MIEF2/MID49 (298). This study re-
vealed that during intrinsic apoptosis Mief1/MiD51-Mief2/
Mid49-KO, and Drp1-KO cells did not exhibit cristae re-
modeling and cytochrome-c release, whereas this was not the
case in Mff-KO cells.
5. Mitochondrial morphofunction affects cell function.
Fis1 overexpression in HeLa cells induced fragmentation and
perinuclear clustering of mitochondria that maintained a
normal Dw and normally sequestered Ca2+ released from the
ER (110). In contrast, Ca2+ entering across the PM was taken
up more slowly by these mitochondria, compatible with a role
of subplasmalemmal mitochondria in modulating the activity
of PM Ca2+ATPases (109). Supported by other studies (77,
434), this demonstrates that mitochondrial morphological
aberrations affect (local) cellular Ca2+ homeostasis. Continued
uptake of multiple ACs by phagocytes (a process known as
efferocytosis) requires DRP1-dependent mitochondrial frag-
mentation in the phagocytes (414). The latter study demon-
strated that mitochondrial fragmentation allows the release of
Ca2+ from the ER into the cytosol to allow phagocytosis by
stimulating Ca2+-mediated vesicle trafficking.
MFN2 KO in POMC (pro-opiomelanocortin) neurons
(involved in the regulation of energy and glucose metabolism)
induced defective POMC processing, loss of mitochondria-ER
contacts, ER stress-induced leptin resistance, hyperphagia,
reduced energy expenditure, and obesity (350). In agree-
ment with these findings, DRP1-induced mitochondrial
fission reduces the sensitivity of POMC neurons for leptin
and glucose (345).
Mitochondrial structure affects cell cycle phase and vice
versa (143). For instance, CDK5 inhibits DRP1 by phos-
phorylation (63) and mitochondria form a hyperfused net-
work at the G1-to-S transition associated with buildup of
cyclin E (268). The latter study also revealed that Dw depo-
larization at early G1 prevents cell cycle entry into S phase.
Perhaps related to this phenomenon, Dw loss in HeLa cells
was linked to homogenization and decompaction of chro-
matin structure, suggesting that the latter is linked to mito-
chondrial function (7).
6. Cell function affects mitochondrial morphofunction. Mi-
tochondrial fusion appears to be ATP dependent (251), sug-
gesting that mitochondria-generated or glycolytic ATP might
(locally) affect mitochondrial fusion dynamics. In this con-
text, high glucose induced mitochondrial fragmentation
paralleled by increased ROS levels (391, 440) and inhibition
of glycolysis impacted MIM fusion more than it did MOM
fusion, whereasDw dissipation prevented MIM fusion but not
MOM fusion (342).
In endothelial cells, mitochondrial morphology in situ was
altered by Ca2+ overload (36). Using the same cell type, it was
observed that KO of ROS-sensitive TRPM2 (transient re-
ceptor potential cation channel M2) channels prevented
glucose-induced mitochondrial fission (1). The latter study
proposed a mechanism in which: (i) TRPM2-mediated Ca2+
entry induces permeabilization of lysosomal membranes and
lysosomal Zn2+ release, and (ii) the released Zn2+ stimulates
mitochondrial DRP1 recruitment to induce fission (1).
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AMPK is a key regulatory protein in cellular energy ho-
meostasis (221). Mitochondrial morphofunction is linked to
cellular bioenergetics via AMPK, which phosphorylates
MFF to enhance DRP1 recruitment and induce mitochondrial
fission (388). Interestingly, unphosphorylated MFF mutants
inhibit mitophagy, connecting AMPK to mitochondrial fis-
sion and mitophagy regulation (388, 442).
Mitochondrial morphology changes were also induced
via altered fusion dynamics during hypoxia-reoxygenation
stress (222). These changes involved formation of donut-
like (toroidal) mitochondrial structures during hypoxia in
glucose-free media and reoxygenation-induced formation of
these structures in glucose-containing medium. Formation of
these donut-like morphologies involved partial mitochon-
drial detachment from the cytoskeleton and mitochondrial
swelling, involving opening of the mPTP or mitochondrial
K+ channels, allowing ‘‘autofusion’’ (222). Computational
analysis suggested that an increase in osmotic potential during
stress conditions induces donut formation and that this process
is reversible (228).
D. Quantification of mitochondrial morphofunction
in living cells
Although substantial progress has been made (24, 142,
266, 355, 407), we are still far from understanding how
the morphofunctional heterogeneity of individual mito-
chondria within a single cell (Figs. 5, 7B, and 11) is main-
tained and how this heterogeneity connects to mitochondrial
and cellular physiology. This lack of insight not only limits
our understanding of mitochondrial morphofunction at the
mechanistic level but also hampers the development and
(large-scale) screening of morphofunction-targeting drugs.
Given the tight connection between mitochondrial and
cellular function, physiological analysis of mitochondrial
morphofunction is ideally carried out within the context of
a living cell (147, 148, 188, 196). If required, this can also
entail analysis of mitochondrial fusion dynamics and/or
motility using photoactivatable proteins (173, 231, 248).
Micropatterned coverslips have been used to ‘‘standardize’’
cell size and shape and allow analysis of mitochondrial
structure under controlled conditions (60). However, alter-
ations in cell shape and cell-substrate adherence might affect
mitochondrial mechanical interactions with the cytoskeleton
and therefore mitochondrial (ultra)structure (19).
Quantification of mitochondrial internal and external
structural parameters (Fig. 12) is not trivial, given the small
dimensions of this organelle (diameter typically <1 lm). For
this reason, mitochondrial ultrastructure has primarily been
visualized by using EM-based approaches, although only in
fixed cell specimens (107, 113, 233). In addition, various
superresolution microscopy techniques (104, 396) have been
applied to mitochondrial (ultra)structural analysis (157).
These include: structured illumination microscopy (124,
358), 4Pi-confocal microscopy (94), STimulated Emission
Depletion microscopy (158), Gated STimulated Emission
Depletion microscopy (28), stochastic optical reconstruction
microscopy (STORM), 3D-STORM, and direct STORM (146,
178) and the ‘‘Zernike Optimized Localisation approach in
3D’’ (12). Unfortunately, the superresolution approaches that
are currently available, have not been optimized for live-cell
imaging and lack a sufficiently high acquisition rate (i.e., with
low subsecond time resolution) and axial imaging depth to
allow real-time analysis of mitochondrial ultrastructural dy-
namics in living cells (104).
Currently, live-cell visualization of mitochondrial mor-
phology and function is primarily carried out by combining
fluorescent cations and/or mitochondria-targeted fluores-
cent proteins (FPs) with confocal laser scanning microscopy
(CLSM) or epifluorescence microscopy. During the past
decade, we and others had developed integrated experimental
and computational strategies for semiautomatic quantifica-
tion of mitochondrial morphology (Fig. 13) (78, 192, 194,
389). Our approach is optimized for analysis of relatively
large flat cells such as primary human skin fibroblasts
(PHSFs) but, after optimization, is also applicable to other
cell types (147). As an alternative, (fixed) non-flat cell types
and/or tissues can be analyzed by using 3D-CLSM (22, 288).
In case of PHSFs, high-content microscopy images are ac-
quired by using cells co-stained with: (i) tetramethylrhodamine
(TMRM), which accumulates in mitochondria in a Dw-
dependent fashion; (ii) Calcein-AM, which accumulates in the
cytosol; and (iii) Hoechst 33258, to stain nucleic acids
(dsDNA). In a collaborative effort, we also developed high-
content protocols for cells co-stained with TMRM and 5-
(and-6)-chloromethyl-2’,7’-dichlorodihydrofluorescein (CM-
‰
FIG. 13. Analysis of mitochondrial morphology in fibroblasts with isolated CI deficiency by microscopy image
processing and quantification. PHSFs were stained with the mitochondria-accumulating cation rhodamine 123 and vi-
sualized by using video-rate confocal microscopy (1 s image acquisition time; 30 images/s were averaged). (A) Illustration
of the image processing strategy using control CT5120 cells. The acquired images were subsequently background corrected
(COR), subjected to an LCS operation, processed by a THF, processed by a median (MED) filter, and thresholded to obtain
a binarized (BIN) black-and-white image. The COR image was masked by the BIN image, yielding a masked (MSK) image
that was colorized (MSK-colorized; blue = low and red= high fluorescence intensity). This processing strategy was de-
scribed in detail elsewhere (186, 192, 194). (B) Image depicting the mitochondrial objects in the MSK-colorized image
sorted according to their size (area) from left to right. This ‘‘mitogram’’ reveals considerable heterogeneity in rhodamine
123 fluorescence signal between and within individual mitochondrial objects. (C) Application of the strategy in (B) on
primary skin fibroblasts of control subjects (CT5120; green) and patients (P) with isolated CI deficiency. The latter carried
mutations in various CI subunit-encoding nDNA genes (NDUFS1, NDUFS2, NDUFS4, NDUFS7, NDUFS8, and NDUFV1).
The boxplot reveals that the mitochondrial formfactor (F; a combined measure of mitochondrial length and degree of
branching) is significantly altered (colorized red) or similar (black) to CT5120 cells (green). (D) Similar to (C), but now
depicting the number of mitochondria per cell (Nc). The interpretation and implications of this data is presented elsewhere
(187, 193, 195). LCS, linear contrast stretch; THF, top-hat filter. Color images are available online.
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H2DCFDA), a reporter of cellular oxidant levels (365). The
acquired images are then processed (Fig. 14A) to allow
extraction of various descriptors of mitochondrial morpho-
function (e.g., number of mitochondria per cell, mitochon-
drial size, TMRM staining intensity; see Table 2). These
descriptors then can be used for quality control and further
evaluated by principal component analysis, univariate/
bivariate/multivariate methods, and machine-learning strat-
egies (Fig. 14) (3, 22, 30, 214, 329). For example, quantita-
tive analysis and machine learning were applied to determine
whether certain mitochondrial morphologies pre-disposed
individual mitochondria to undergo subsequent fission or
fusion (421). This revealed that mitochondrial perimeter and
solidity (i.e., the compactness of its shape) positively and
negatively correlated with the occurrence of a mitochondrial
fission or fusion event, respectively. It was concluded that the
mechanical properties of the MOM might influence mito-
chondrial fission and fusion probability (421).
E. A brief primer on the role of mitochondrial
(ultra)structure in mitochondrial bioreactions
Understanding the dynamics and design principles of
biochemical reactions within an inhomogeneous cell com-
partment such as the mitochondrion still represents a major
challenge (127, 373). This is due to the fact that mitochon-
drial bioreactions are spatially compartmentalized, meaning
that they generally involve the conversion of (im)mobile
substrates by (im)mobile enzymes into (im)mobile products.
As a consequence, these reaction systems require biomolecule
transport and/or diffusion within or between mitochondria and,
therefore, constitute ‘‘reaction-diffusion’’ systems (226, 419).
It is higly likely that changes in mitochondrial (ultra)structure
affect mitochondrial function by modulating mitochondrial
bioreactions, for instance by: (i) changes in MOM surface
area and matrix volume, and (ii) changes in the extent of
MIM folding, which affects cristae number/morphology/
dimensions/topology. In addition, these bioreactions will be
affected by alterations in matrix solvent properties, including
ionic strength, viscosity, and macromolecular crowding. In
this manner, changes in mitochondrial (ultra)structure and
matrix physicochemical parameters could affect many
diffusion-influenced mitochondrial reactions, including: (i)
metabolic reactions (ATP, metabolites), (ii) protein folding,
(iii) protein–protein interactions (signaling and macromo-
lecular assembly), and (iv) mtDNA replication/translation.
In addition, physicochemical differences between individ-
ual mitochondria could be underlying Dw and functional
inhomogeneities between and within single mitochondria.
Although the general properties of reaction-diffusion
systems are relatively well understood, detailed quantitative
information on solute diffusion and biomolecular interactions
in the mitochondrial matrix is currently lacking (25, 91, 97,
155, 295, 351). The analysis of protein diffusion in the mi-
tochondrial matrix generally involves expression of an FP
with favorable spectral and biophysical properties. FP mo-
bility then can be determined by using fluorescence recovery
after photobleaching (FRAP), fluorescence loss in photo-
bleaching (FLIP; Fig. 15), and/or fluorescence correlation
spectroscopy (FCS) analysis (10, 85, 187, 189). Given the
complex nature of FP diffusion within the matrix (i.e., it is
affected by the molecular weight (MW) of the FP, cristae
diffusion barriers, mitochondrial length and diameter, the
size of the bleach region, and solvent viscosity), one will
always measure an ‘‘apparent’’ FP fluorescence recovery
time (FRAP/FLIP) or diffusion constant (FCS). This neces-
sitates the use of a diffusion model in which various pa-
rameters are experimentally constrained (i.e., mitochondrial
dimensions, number of cristae, FP concentration, and FRAP
region size) (84). Applying this strategy in HEK293 cells, we
demonstrated that, as expected (303), FP diffusion in the
mitochondrial matrix is MW-dependent. Unexpectedly (305,
401), our experiments also revealed that cristae severely
hinder FP diffusion. This suggests that differences in mito-
chondrial ultrastructure, as observed between cell types and
between healthy and pathological conditions (403, 447) af-
fect diffusion-limited reactions in the mitochondrial matrix.
Moreover, it is highly probable that changes in mitochondrial
metabolic state accompanied by orthodox-to-condensed tran-
sitions (132, 335) will also affect intra-matrix solute diffusion.
This implies that alterations in mitochondrial nanostructure, as
observed during numerous (patho)physiological conditions,
can affect the properties of intramatrix reaction-diffusion sys-
tems and therefore mitochondrial and cellular function (84).
In contrast to FPs in the matrix, early evidence suggested
that MIM-embedded ETC complexes exhibit restricted dif-
fusion (117). Indeed, after artificial cell fusion, FP-labeled
ETC complexes and CV displayed a patterned arrangement,
possibly as a result of their incorporation in supercomplexes
within cristae (275). This suggests that after mitochondrial
fusion complete equilibration of ETC complexes, being
MIM-embedded, is slow relative to FP diffusion in the mi-
tochondrial matrix.
The volume of the reaction compartment is a key param-
eter in chemical reaction dynamics. Changes in mitochon-
drial volume (Fig. 7A) were induced by alterations in
OXPHOS function, ischemia/reperfusion, anoxia, and apo-
ptotic signaling. Evidence was provided that these volume
changes (co)control mitochondrial function (48, 225, 291).
Mitochondrial volume depends on the osmotic balance be-
tween the cytosol and the mitochondrion (167) and is mainly
regulated by potassium (K+) ions (Fig. 1), which enter and
leave the mitochondrial matrix in a Dw-dependent manner
(341). The latter study revealed that Dw depolarization in-
duced mitochondrial swelling and impaired mitochondrial
motility in neuronal cells. Together with K+, also Ca2+ ions
are important in triggering mitochondrial swelling, especially
when the matrix influx of these ions is increased and/or their
matrix efflux is decreased (160). Under these conditions, the
osmotic pressure and water accumulation in the mitochon-
drial matrix is increased, leading to mitochondrial swelling.
Importantly, the rate at which water enters the mitochondrial
matrix is dependent not only on the osmotic gradient with the
cytosol but also on the water permeability of the MIM (167).
In addition, it was suggested that metabolic water produced
by the OXPHOS system is involved in the regulation of mi-
tochondrial volume (48). A water channel (aquaporin-8/
AQP8; Fig. 1) was detected in the MIM of rat liver mito-
chondria and proposed to mediate rapid matrix expansion,
thereby regulating the activity of the ETC and CV (42).
Whether this AQP8-mediated influx is a general mechanism
across tissues and whether AQP8 also participates in the
trans-MIM transport of other molecules still remains to be
determined (160, 209).
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Physiologically relevant changes in matrix volume
(Fig. 7A) are moderate, reversible, and linked to regulation of
the ETC and mitochondrial ATP production (160). It appears
that mitochondrial osmotic pressure regulates mPTP opening
(15) and that massive swelling of the mitochondrial matrix
associated with long-term (Ca2+-induced) mPTP opening
leads to cell death by compromising mitochondrial function
(291). Mechanistically, evidence in rat liver mitochondria
suggests that this mPTP regulation involves volume-induced
changes in matrix concentration of mPTP regulatory factors
(290). In this context, the latter study revealed that mito-
chondrial shrinkage stimulated mPTP inhibition by Mg2+ and
FIG. 14. High-content analysis (‘‘cellomics’’) of mitochondrial morphofunction. PHSFs (CT5120) were stained with
the mitochondria-accumulating cation TMRM and visualized by using fluorescence microscopy. The acquired images were
processed as described in Figure 13A. (A) Typical TMRM fluorescence image used to illustrate the high-content analysis.
(B) Heat map depicting the numerical value of 42 morphofunctional descriptors (horizontal axis; Table 2) for each of the
217 mitochondrial objects in (A) (vertical axis). These data were sorted from large (top) to small (bottom) values of
mitochondrial size (descriptor ‘‘Area’’; marked in red) and Log10 scaled. Individual horizontal rows represent the mor-
phofunctional ‘‘fingerprint’’ for each mitochondrial object (30), which can be averaged at the level of individual cells and
cell populations to obtain information at different complexity levels. (C) Degree of linear correlation (calculated by using
Pearson’s R) between the individual descriptors in (B). Negative and positive correlations are depicted in blue and red,
respectively. This correlation plot also can be considered a cellular fingerprint of mitochondrial morphofunction in the
analyzed cell. The data presented in this figure can be explored and classified by using various computational techniques
(147, 411), allowing time analysis, comparison of different cells and cell types, culture conditions, and modulation
strategies. Color images are available online.
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Table 2. Descriptors of Mitochondrial Morphofunction for Tetramethylrhodamine
No.a Descriptor Symbol Definition/meaning of descriptorb
1 Aspect ratio AR Ratio between major axis and minor axis of an ellipse
equivalent to object: measure of mitochondrial length.
2 Area/Box Ab Ratio between the area of an object and the area of its
bounding box.
3 Box XonY Bxy Ratio between the width and the height of an object’s
bounding box.
4 Density mean Dm Average intensity of object (grayvalue): average mitochon-
drial intensity of TMRM signal.
5 Axis minor Axm Length of minor axis of ellipse with same moments of order
1 and 2 as object (pixels).
6 Diameter maximum Dimax Length of the longest line joining two points of the object’s
outline and passing through the object’s centroid (pixels).
7 Diameter minimum Dimin Length of the shortest line joining two points of the object’s
outline and passing through the object’s centroid (pixels).
8 Diameter mean Dim Average length of diameters measured at 2-degree intervals
and passing through the object’s centroid.
9 Radius maximum Rmax Minimum distance between the object’s centroid and outline
(pixels).
10 Radius minimum Rmin Maximum distance between the object’s centroid and
outline (pixels).
11 Perimeter ellipse P1 The perimeter of the ellipse surrounding the outline of each
object (pixels).
12 Radius ratio Rr Ratio between Rmax and Rmin.
13 Roundness F Perimeter2/(4*p*Area; or Formfactor or F): measure of
mitochondrial length and degree of branching.
14 Length Le Feret diameter (caliper length) along the major axis of the
object (pixels).
15 Width Wi Feret diameter (caliper length) along the minor axis of the
object (pixels).
16 Perimeter2 P2 Chain code length of the outline (pixels).
17 IOD IOD Integrated optical density of all objects (grayvalue): sum of
all mitochondrial TMRM intensity values.
18 Perimeter convex Pc Perimeter of the convex outline of the object (pixels).
19 Perimeter P3 Length of the object’s outline (pixels).
20 Perimeter ratio Pr Ratio of convex perimeter to perimeter.
21 Area polygon Ap Area included in the polygon defining the object’s outline
(same polygon as used for perimeter).
22 Count Cou Size-weighted object ‘‘count’’ (number of objects).
23 Box width Bw Width of the object’s bounding box (pixels).
24 Box height Bh Height of the object’s bounding box (pixels).
25 Feret minimum Fmin Smallest feret (caliper) length (pixels).
26 Feret maximum Fmax Longest feret (caliper) length (pixels).
27 Feret mean Fm Average feret (caliper) length (pixels).
28 Density minimum Dmin Minimum density inside object (grayvalue).
29 Density maximum Dmax Maximum density inside object (grayvalue).
30 Density standard deviation Dstdv Standard deviation of intensity or density inside object
(grayvalue).
31 Margination Ma Distribution of intensity between the center of an object and
the edge of the object.
32 Area Area Area of the object (pixels).
33 Center X CX X coordinate of the object’s centroid (pixel position).
34 Center Y CY Y coordinate of the object’s centroid (pixel position).
35 Angle Angle Angle between the major axis of the object and the vertical.
36 Axis (major) Axmaj Length of the major axis of the ellipse with the same
moments of order 1 and 2 as the object.
37 Fractal dimension FD Fractal dimension of the object’s outline.
38 Center X (mass) CmassX Intensity-weighed centroid X-position (pixel position).
39 Center Y (mass) CmassY Intensity-weighed centroid Y-position (pixel position).
40 Heterogeneity Het Fraction of pixels that deviate more than a certain range
(here 10%) from the average intensity.
41 Density Sum Dsum Sum of intensity inside the object (grayvalue).
42 Perimeter3 P4 Corrected chain code perimeter (pixels).
aAdapted from (30, 147).




ubiquinone 0 (Ub0) and decreased the effect of the mPTP-
inhibitor Cyclosporin A. It is currently unknown how the
transition from physiological to pathological volume changes
(Fig. 7A) is exactly regulated, although a role for ROS and
metabolic stress was proposed (160).
F. Small-molecule targeting of mitochondrial
morphology
The concept of mitochondrial morphofunction strongly
suggests that mitochondrial function can be modulated by
rational manipulation of mitochondrial (ultra)structure and
vice versa. This is of great relevance for the large number of
pathological conditions in humans where the mitochondrial
structure-function relationship is disturbed (11, 328).
Various small molecules have been developed that inhibit
DRP1 activity. These include Dynasore (237), Mdivi1 (47),
and the P110-TAT peptide (130, 166, 320). All three of these
molecules inhibited mitochondrial fission in various studies,
suggesting that they might be useful to reduce excessive
mitochondrial fission and oxidative stress in neurons affected
in AD, Parkinson’s disease, and HD (328). However, in case
FIG. 15. FLIP analysis of single mitochondrion in HEK293 cells. HEK293 cell lines were created that stably expressed
mitochondria-targeted GFP (COX8-AcGFP1) or a GFP-tagged version of the NDUFS3 subunit of CI (NDUFS3-AcGFP1).
Analysis of single mitochondria by FRAP revealed that AcGFP1 was fully mobile, whereas NDUFS3-AcGFP1 was partially
immobilized in the mitochondrial matrix (85). Here, we used FLIP analysis to determine the submitochondrial localization
of immobile NDUFS3-AcGFP1. (A) In COX8-AcGFP1 cells, repetitive bleaching of mitochondrial AcGFP1 using a 1.4 lm
square bleach region induced complete loss of fluorescence in the bleach and FLIP region within 12 s. Visual inspection
revealed that AcGFP1 fluorescence was completely lost from the mitochondrial filament (inset). (B) In contrast, for
NDUFS3-AcGFP1 cells, repetitive AcGFP1 bleaching induced complete fluorescence loss in the bleach region but not in the
FLIP region (arrowhead). In this case, visual inspection confirmed that NDUFS3-AcGFP1 fluorescence was absent in the
bleach region but not outside this region. (C) Explanation of the obtained results with NDUFS3-AcGFP1 cells. Repetitive
photobleaching induces loss of fluorescence for the mobile fraction of NDUFS3-AcGFP1 but not for the immobile fraction
of NDUFS3-AcGFP1, which appears to be localized (arrowheads). (D) Magnification of a typical FLIP experiment
illustrating the localization of the immobile NDUFS3-AcGFP1 fluorescence fraction (arrowhead). This might represent
local compartments of the mitochondrial matrix that restrict NDUFS3-AcGFP1 diffusion and/or NDUFS3-AcGFP1 that is
membrane bound in CI (sub)complexes or ETC supercomplexes. (C) and (D) were taken from (83). ETC, electron transport
chain; FLIP, fluorescence loss in photobleaching. Color images are available online.
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of Mdivi1, off-target effects have been described, including
inhibition of K+ channels and membrane potential in HL-1
murine atrial cardiomyocytes (370) as well as CI inhibition
and modulation of mitochondrial ROS production (34, 322).
The pros and cons of the use of Mdivi1 as a specific DRP1
inhibitor were recently discussed (368). It was concluded that
although the current evidence supports the previously de-
scribed Mdivi1 bioactivity, use of this molecule requires in-
clusion of stringent positive controls that directly demonstrate
its effect on mitochondrial fission. Importantly, DRP1 also
mediates peroxisomal fission (353, 354) and exerts various
other functions (Table 1). This means that mitochondrial fis-
sion cannot be specifically modulated by targeting of DRP1.
In addition to DRP1-targeting molecules, a cell-permeant
fusogenic peptide (TAM-MP1Gly) was developed that destabi-
lized the fusion-constrained configuration of MFN2, thereby
promoting the fusion-permissive conformation (105). Interest-
ingly, a small-molecule mimetic of the MFN2 peptide-peptide
interface (‘‘Chimera B-A/long’’) allosterically activated MFN2,
thereby promoting mitochondrial fusion (333). This small
molecule mitigated mitochondrial clumping,Dw depolarization,
fragmentation, and dysmotility in CMT2A mutant neurons.
The strategies described earlier focus on inhibition and
stimulation of mitochondrial fission and fusion, respec-
tively, to improve mitochondrial function. However, alter-
ing mitochondrial (ultra)structure by exogenous means also
affects the cell’s susceptibility to death-inducing agents. The
latter is likely to be cell type- and condition-dependent. For
example, mitochondrial fragmentation induced by DRP1
overexpression protected against the efficacy of CER-induced,
Ca2+-dependent, apoptosis (378). In contrast, DRP1 knock-
down induced mitochondrial filamentation and protected
against necroptosis and apoptosis induced by CI inhibition in
melanoma cell models (20).
In our own studies, we observed that Trolox (6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid), a water-
soluble vitamin E-derived antioxidant, increased the levels of
fully assembled and active CI in primary skin fibroblasts of
children with isolated CI deficiency (191). In these patient
cells, Trolox displayed pleiotropic effects since it: (i) reduced
ROS levels, (ii) normalized aberrant cytosolic Ca2+/ATP
handling, and (iii) restored Dw depolarization (90, 191).
Mechanistic studies in healthy primary skin fibroblasts re-
vealed that Trolox: (i) reduced ROS-induced formation
of chloromethyl 2¢,7¢-dichlorofluorescein, (ii) did not affect
oxidation of the ROS sensor HEt (hydroethidium), (iii) did
not affect mitochondrial NAD(P)H levels orDw, (iv) reduced
lipid peroxidation, (v) increased the expression and activity
of all OXPHOS complexes, (vi) stimulated mitochondrial
routine and maximal oxygen consumption, and (vii) pre-
vented hydrogen peroxide-induced aberrations in cytosolic
Ca2+ handling (89). Within the context of this review, it is
important that the latter study demonstrated that Trolox
stimulated the protein levels of MFN2 but not of DRP1 and
FIS1 in mitochondria-enriched fractions from PHSFs and
Chinese Hamster Ovary cells. Moreover, Trolox-induced sti-
mulaton of mitochondrial filamentation was glutathione-
dependent and absent inMfn1-/-,Mfn2-/-, andMfn1-/-Mfn2-/-
cells. Given the fact that the Trolox effects were observed in
healthy fibroblasts, we proposed that Trolox reduces the levels
of endogenous CM-H2DCF oxidizing signaling ROS, which
increases the levels of mitochondria-attached mitofusins and
therefore induces mitochondrial filamentation (89). Function-
ally, this filamentation is associated with increased mito-
chondrial function as exemplified by increased activity of
OXPHOS complexes and higher mitochondrial oxygen con-
sumption. Given these pleiotropic effects, it remains to be
determined whether Trolox and other antioxidants can exert
positive effects by targeting aberrant mitochondrial (ul-
tra)structure in human disease (21, 185, 348).
V. Conclusions
In this review, we highlighted the basic mechanisms and
experimental evidence, demonstrating a tight and multidirec-
tional connection between mitochondrial internal structure,
external structure, and function. This supports the novel concept
of ‘‘mitochondrial morphofunction.’’ Currently, a comprehen-
sive understanding of mitochondrial morphofunction is still
lacking, and obtaining this information requires quantitative
information at the level of individual mitochondria within sin-
gle living cells. In addition, more detailed insights are required
into how the volume and complex nanoarchitecture of the
mitochondrion impacts its biochemistry. It is expected that
a detailed understanding of mitochondrial morphofunction
will significantly contribute to deciphering: (i) why indi-
vidual mitochondria display heterogeneous (ultra)structural
and functional properties between and within cells, (ii) how
mitochondrial (ultra)structure affects mitochondrial and
cellular bioreactions and therefore mitochondrial and cellular
functioning, (iii) how exogenous manipulation of mitochon-
drial (ultra)structure can be used to ‘‘control’’ mitochondrial
function, and (iv) whether such manipulation is therapeutically
relevant in human diseases with disturbed mitochondrial
morphofunction.
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Abbreviations Used
AC¼ apoptotic cell




AMPK¼AMP-activated protein kinase A
ANT¼ adenine nucleotide translocator
AQP8¼ aquaporin-8
ATP¼ adenosine triphosphate







CLSM¼ confocal laser scanning microscopy
CM¼ cristae membrane
CoMIC¼ constrictions of the mitochondrial inner
compartment




ETC¼ electron transport chain
FAs¼ fatty acids
FCS¼ fluorescence correlation spectroscopy
FIS1¼ fission protein 1
FLIP¼ fluorescence loss in photobleaching
FPs¼ fluorescent proteins










HR1¼ heptad repeat domain 1
IBM¼ inner boundary membrane
IF1¼ inhibitory factor 1
IMJs¼ inter-mitochondrial junctions
IMPs¼ integral membrane proteins
IMS¼ intermembrane space






MFN1/MFN2¼mitofusin 1 and 2
MFNs¼mitofusins
MIC10¼MICOS complex subunit 10
MICOS¼mitochondrial contact site
and cristae organization
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Abbreviations Used (Cont.)
MIEF1/MID51¼mitochondrial elongation factor 1
MIEF2/MID49¼mitochondrial elongation factor 2
MIGA¼mitoguardin
MIM¼mitochondrial inner membrane
MIRO1¼mitochondrial Rho GTPase 1













OPA1¼ optic atrophy protein 1
OPA3¼ optic atrophy 3
OXPHOS¼ oxidative phosphorylation
PA¼ phosphatidic acid
PA-PLA1¼ PA-preferring phospholipase A1
PARL¼ Presenilin-associated rhomboid-like
PC¼ phosphatidylcholine
PDIA1¼ protein disulfide isomerase A1
PE¼ phosphatidylethanolamine
PHB2¼ prohibitin 2
PHSFs¼ primary human skin fibroblasts
PiC¼ Pi/H+ symporter
PINK1¼ PTEN-induced putative kinase 1





PP2A/Bb2¼ protein phosphatase 2A/Bb2
PTMs¼ post-translational modifications
Q¼Coenzyme Q10
ROCK1¼ rho-associated coiled coil-containing
protein kinase 1
ROS¼ reactive oxygen species
SAM¼ protein sorting and assembly machinery
Sp¼ splice variant
STORM¼ stochastic optical reconstruction
microscopy
TCA¼ tricarboxylic acid
TIM¼ protein translocase of the MIM
TM¼ transmembrane domain
TMEM11¼ transmembrane protein 11
TMRM¼ tetramethylrhodamine
TOM¼ protein translocase of the MOM
TRPM2¼ transient receptor potential cation
channel M2
VDAC¼ voltage-dependent anion channel
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